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1. PUBLIC HEALTH STATEMENT 
This statement was prepared to give you information about 1,3-dinitrobenzene (1,3-DNB) and 
1,3,5-trinitrobenzene (1,3,5-TNB) and to emphasize the human health effects that may result 
from exposure to them. The Environmental Protection Agency (EPA) has identified 1,397 
waste sites as the most serious in the nation. These sites make up the National Priorities List 
(NPL) and are the sites targeted for long-term federal clean-up activities. 1,3-DNB and 
1,3,5-TNB have been found in at least 19 of the sites on the NPL. However, the number of 
NPL sites evaluated for 1,3-DNB and 1,3,5-TNB is not known. As EPA evaluates more sites, 
the number of sites at which 1,3-DNB and 1,3,5-TNB are found may increase. This 
information is important because exposure to 1,3-DNB and 1,3,5-TNB may cause harmful 
health effects and because these sites are potential or actual sources of human exposure to 
1,3-DNB and 1,3,5-TNB. 
When a chemical is released from a large area, such as an industrial plant, or from a 
container, such as a drum or bottle, it enters the environment as a chemical emission. This 
emission, which is also called a release, does not always lead to exposure. You can be 
exposed to a chemical only when you come into contact with the chemical. You may be 
exposed to it in the environment by breathing, eating, or drinking substances containing the 
chemical or from skin contact with it. 
If you are exposed to a hazardous chemical such as 1,3-DNB or 1,3,5-TNB, several factors 
will determine whether harmful health effects will occur and what the type and severity of 
those health effects will be. These factors include the dose (how much), the duration (how 
long), the route or pathway by which you are exposed (breathing, eating, drinking, or skin 
contact), the other chemicals to which you are exposed, and your individual characteristics 
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1. PUBLIC HEALTH STATEMENT 
1.1 WHAT ARE 1,3-DNB and 1,3,5-TNB? 
1,3-DNB and 1,3,5-TNB are synthetic substances that are used in explosives. In making 
1,3,5-TNB, 1,3-DNB is often made first. Both 1,3-DNB and 1,3,5-TNB are formed as 
by-products when another explosive, trinitrotoluene (TNT), is made. 1,3-DNB is also used to 
make certain dyes, as an intermediate in the synthesis of .organic chemicals, and in the 
plastics manufacturing industry. 1,3,5-TNB is used in .making rubber. Other names for 
1,3-DNB include m-dinitrobenzene, 1,3-dinitrobenzol, 2,4-dinitrobenzene, binitrobenzene, and 
m-DNB. Other names for 1,3,5-TNB include benzite, s-trinitrobenzene, sym-trinitrobenzene, 
symmetric trinitrobenzene, syn-trinitrobenzene, and TNB. Both 1,3-DNB and 1,3,5-TNB are 
yellow, crystal-like solids at room temperature. They may exist in the air in very small 
amounts as a dust or a vapor and can dissolve in certain liquids. If either compound is put 
under very high heat, it will explode. These compounds have no odor or taste. 
In this profile, 1,3-DNB and 1,3,5-TNB are discussed together because they have very similar 
structures. Since the two compounds are similar in structure, their toxic effects may not be 
very different. More information on the chemical and physical properties of 1,3-DNB and 
1,3,5-TNB is found in Chapter 3. More information on the production and use of 1,3-DNB 
and 1,3,5-TNB is in Chapter 4. 
1.2 WHAT HAPPENS TO 1,3-DNB or 1,3,5-TNB WHEN IT ENTERS THE
 ENVIRONMENT? 
Waste discharges from Army ammunition plants or other chemical manufacturers are the 
primary sources for the releases of both compounds to air, water, and soil. They can also 
enter the environment from their use as explosives and from spills or improper disposal. It is 
unlikely that either compound would normally be.found in the air. However, under some 
industrial use conditions, some 1,3-DNB and 1,3,5-TNB may enter the air in the form of dust. 
We have very little information about what happens to 1,3-DNB and 1,3,5-TNB in the air. 
The small amounts of 1,3,5-TNB that may enter the air are likely to break down very slowly. 
It might persist for many years in the air. 1,3-DNB is also likely to break down in the air; 
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however, we do not know how long this would take. Both compounds are slightly soluble in 
water. 1,3-DNB evaporates slowly from water; 1,3,5-TNB does not evaporate from water. 
Neither compound sticks strongly to soil; therefore, both can move through soil into 
groundwater. I,3-DNB breaks down slowly in water and soil. It stays for days to months in 
water. Although 1,3,5-TNB probably breaks down in water and soil, we do not know how 
long this takes. Neither compound is likely to build up in fish or humans. See Chapters 4 
and 5 for more information on 1,3-DNB and 1,3,5-TNB in the environment. 
1.3 HOW MIGHT I BE EXPOSED TO 1,3-DNB OR 1,3,5-TNB? 
Most of the population will not be exposed to 1,3-DNB or 1,3,5-TNB. If you live or work 
near an Army ammunition plant or other chemical manufacturer, you may be exposed to these 
compounds by contaminated drinking water, food, air, or soil. At this time, it is not known 
how much of these compounds you might consume or how much might be in the air. We 
also do not know how many workers are exposed to the compounds. Both 1,3-DNB and 
1,3,5-TNB have been found in water and soil at some Army ammunition plants. Groundwater 
samples had levels of 1,3-DNB ranging from 0.0012 to 0.195 parts per one million parts of 
water (ppm). 1,3-DNB was present at higher levels in soil, with concentrations ranging from 
0.77 to 1.5 ppm. 1,3,5-TNB was also present in groundwater samples at concentrations up to 
8 ppm. 1,3,5-TNB was present at higher levels in soil, with concentrations ranging from 368 
to 3,920 ppm. See Chapter 5 for more information on exposure to 1,3-DNB and 1,3,5-TNB. 
1.4 HOW CAN 1,3-DNB AND 1,3,5-TNB ENTER AND LEAVE MY BODY? 
1,3-DNB can enter your bloodstream if you breathe it in the air or get it on your skin. There 
is no information on how 1,3,5-TNB can enter or exit your body. Exposure of the general 
population to 1,3-DNB or 1,3,5-TNB is not likely, so most people exposed to 1,3-DNB have 
come in contact with it in their work place. Results of studies in people and animals show 
that 1,3-DNB enters the body very quickly through the skin or lungs. Once 1,3-DNB is 
inside your body, it breaks down quickly. 1,3-DNB and its related breakdown products also 
exit the body very quickly in the urine. Some breakdown products of 1,3-DNB may also 
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leave in the feces. Results of studies in people and animals show that most of the 1,3-DNB 
exits the body within 2 to 3 weeks after exposure. Chapter 2 has more information on how 
1,3-DNB can enter and leave the body. 
1.5 HOW CAN 1,3-DNB AND 1,3,5-TNB AFFECT MY HEALTH? 
1,3-DNB and 1,3,5-TNB are suspected to cause similar health effects. Exposure to high 
concentrations of 1,3-DNB can reduce the ability of blood to carry oxygen and can cause 
your skin to become bluish in color. If you are exposed to 1,3-DNB for a long time, you can 
develop a reduction (or loss) in the number of red blood cells (anemia). Other symptoms of 
1,3-DNB exposure include headache, nausea, and dizziness. We do not know if there are any 
long-term health effects of exposure to 1,3-DNB or 1,3,5-TNB in people. We also do not 
know if 1,3-DNB or 1,3,5-TNB causes birth defects or cancer in people. 
Results of studies in animals show that effects of 1,3-DNB and 1,3,5-TNB on the blood are 
similar to the effects seen in people. Results from animal studies also show some other 
effects of 1,3-DNB exposure, such as behavioral changes, damaged sperm production, and 
male reproductive damage. We do not know if these other effects could occur in people. 
Animal studies also show that, in certain cases, a large enough single oral dose of 1,3-DNB 
can cause death. Neither 1,3-DNB or 1,3,5-TNB have been tested to see whether or not they 
cause cancer in animals. 
The Environmental Protection Agency has determined that 1,3-DNB is not classifiable as to 
its human carcinogenicity and has not classified the carcinogenicity of 1,3,5-TNB. 
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1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN
 EXPOSED TO 1,3-DNB OR 1,3,5-TNB? 
No tests are available commercially to determine if you have been exposed to 1,3-DNB or 
1,3,5-TNB. There are tests to detect 1,3-DNB and its breakdown products in the blood and 
urine of exposed animals, but these tests have not been used for people. Refer to Chapters 2 
and 6 for more information on these tests for animals. 
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO
 PROTECT HUMAN HEALTH? 
The government has developed regulations and guidelines for 1,3-DNB and 1,3,5-TNB. 
These are designed to protect the public from the harmful health effects of the chemicals. 
EPA has classified 1,3-DNB and 1,3,5-TNB as hazardous wastes that must meet certain 
disposal requirements. The Department of Transportation has many regulations on the 
transportation of explosives including 1,3-DNB and 1,3,5-TNB. 
The Occupational Safety and Health Administration (OSHA) regulates levels of 1,3-DNB in 
the workplace. The maximum allowable amount of 1,3-DNB in workroom air during an 
8-hour workday, 40-hour workweek, is 1.0 milligram per cubic meter (mg/m3). 
See Chapter 7 for more information on regulations and guidelines on 1,3-DNB and 
1,3,5-TNB. 
1.8 WHERE CAN I GET MORE INFORMATION? 
If you have any more questions or concerns, please contact your community or state health or 
environmental quality department or: 









6 1,3-DNB AND 1,3,5-TNB 
1. PUBLIC HEALTH STATEMENT 
This agency can also tell you where to find the nearest occupational and environmental health 
clinic. These clinics specialize in the recognition, evaluation, and treatment of illness 
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2. HEALTH EFFECTS 
2.1 INTRODUCTION 
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 
other interested individuals and groups with an overall perspective of the toxicology of 
1,3-dinitrobenzene and 1,3,Minitrobenzene (1,3-DNB and 1,3,5-TNB) and a depiction of significant 
exposure levels associated with various adverse health effects. It contains descriptions and evaluations 
of studies and presents levels of significant exposure for 1,3-DNB and 1,3,5-TNB based on 
toxicological studies and epidemiological investigations. 
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals address the needs of persons living or working near hazardous 
waste sites, the information in this section is organized first by route of exposure- inhalation, oral, 
and dermal-and then by health effect-death, systemic, immunological and lymphoreticular, 
neurological, reproductive, developmental, genotoxic, and carcinogenic effects. These data are 
discussed in terms of three exposure periods-acute (14 days or less), intermediate (15-364 days), and 
chronic (365 days or more). 
Levels of significant exposure for each route and duration are presented in tables and illustrated in 
figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or 
lowestobserved-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the 
studies. LOAELs have been classified into “less serious” or “serious” effects. “Serious” effects are 
those that evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute 
respiratory distress or death). “Less serious” effects are those that are not expected to cause significant 
dysfunction or death, or those whose significance to the organism in not entirely clear. ATSDR 
acknowledges that a considerable amount of judgment may be required in establishing whether an end 
point should be classified as a NOAEL, “less serious” LOAEL, or “serious” LOAEL, and that in some 
cases, there will be insufficient data to decide whether the effect is indicative of significant 
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these end points. ATSDR believes that there is sufficient merit in this approach to warrant an attempt 
at distinguishing between “less serous” and “serious” effects. The distinction between “less serious” 
effects. and “serious” effects is considered to be important because it helps the users of the profiles to 
identify levels of exposure at which major health effects start to appear. LOAELs or NOAELs should 
also help to determine whether or not the effects vary with dose and/or duration, and place into 
perspective the possible significance of these effects to human health. 
The significance of the exposure levels shown in the tables and figures may differ depending on the 
user’s perspective. For example, physicians concerned with the interpretation of clinical findings in 
exposed persons may be interested in levels of exposure associated with “serious” effects. Public 
health officials and project managers concerned with appropriate actions to take at hazardous waste 
sites may want information on levels of exposure associated with more subtle effects in humans or 
animals (LOAEL) or exposure levels below which no adverse effects (NOAEL) have been observed. 
Estimates of levels posing minimal risk to humans (Minimal Risk Levels or MRLs) may be of interest 
to health professionals and citizens alike. 
Estimates of exposure levels posing minimal risk to humans (Minimal Risk Levels or MRLs) have been 
made for 1,3-DNB and 1,3,5-TNB. An MRL is defined as an estimate of daily human exposure to a 
substance that is likely to be without an appreciable risk of adverse effects (noncarcinogenic) over a 
specified duration of exposure. MRLs are derived when reliable and sufficient data exist to identify the 
target organ(s) of effect or the most sensitive health effect(s) for a specific duration within a given route 
of exposure. MRLs are based on noncancer health effects only and do not reflect a consideration of 
carcinogenic effects.. Marls can be derived for acute, intermediate, and chronic duration exposures for 
inhalation and oral routes. Appropriate methodology does not exist to develop MRLs for dermal 
exposure. 
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 
1990b), uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges 
additional uncertainties inherent in the application of the procedures to derive less than lifetime MRLs. 
As an example, acute inhalation MRLs may not be protective for health effects that are delayed in 
development or are acquired following repeated acute insults, such as hypersensitivity reactions, 
asthma, or chronic bronchitis. As these kinds of health effects data become available and methods to 
assess levels of significant human exposure improve, these MRLs will be revised. 
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A User’s Guide has been provided at the end of this profile (see Appendix A). This guide should aid 
in the interpretation of the tables and figures for Levels of Significant Exposure and the MRLs. 
2.2.1 lnhalation Exposure 
1,3-DNB and 1,3,5-TNB are nitrobenzene compounds that are structurally similar. The only difference 
in structure between 1,3-DNB and 1,3,5-TNB is the presence of an additional nitro group in 
1,3,5-TNB. There is no information on 1,3,5-TNB exposure by the inhalation route. There is also 
very little information regarding inhalation exposure to 1,3-DNB. 
The one study found on inhalation exposure is a report of an occupational exposure to 1,3-DNB 
(Okuba and Shigeta 1982).  The study indicates that inhalation was the main route of exposure, while 
skin absorption was much less important.  Since precise labels of exposure are not known, the results are 
not presented in a table or figure. 
2.2.1.1 Death 
No studies were located regarding lethal effects in humans or animals after inhalation exposure to 
1,3-DNB or 1,3,5-TNB. 
2.2.1.2. Systemic Effects 
No studies were located regarding gastrointestinal, musculoskeletal, dermal, or ocular effects in 
humans or animals after inhalation exposure to 1,3-DNB or 1,3,5-TNB. 
Respiratory Effects.  No studies were located regarding respiratory effects in humans after 
inhalation exposure to 1,3,5-TNB.  One retrospective study (Okuba and Shigeta 1982) of acute 
occupational exposure to 1,3-DNB dust particles was located.  Six workers were removing crystallized 
1,3-DNB from tank and were protected with gauze masks and rubber gloves.  Exposure occurred 
over a period of 6 days.  By the end of the exposure period, some of the workers complained of slight 
dyspnea upon exertion.  Inhalation was considered to be a primary route of exposure because a 
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information on the concentration of 1,3-DNB in the air, the amount of particulate 1,3-DNB deposited 
on workers’ skin, and the exact duration of exposure. 
No studies were located regarding respiratory effects in animals after inhalation exposure to 1,3-DNB 
or 1,3,5-TNB. 
Cardiovascular Effects. No studies were located regarding cardiovascular effects in humans after 
inhalation exposure to 1,3,5-TNB. One retrospective study (Okubo and Shigeta 1982) of acute 
occupational exposure to 1,3-DNB dust particles was located. Six workers were removing crystallized 
1,3-DNB from a tank and were protected with gauze masks and rubber gloves. Exposure occurred 
over a period of 6 days. By the end of the exposure period, some of the workers complained of 
palpitations upon exertion. Inhalation was considered to be a primary route of exposure because a 
relatively small skin area (face and neck) was exposed. Limitations of this study include lack of 
information on the concentration of 1,3-DNB in the air, the amount of particulate 1,3-DNB deposited 
on workers’ skin, and the exact duration of exposure. 
Hematological Effects. No studies were located regarding hematological effects in humans after 
inhalation exposure to 1,3,5-TNB. Cyanosis was the first symptom noticeable within a day after an 
acute human exposure to I,3-DNB. Slight-to-moderate anemia with a decrease in specific gravity of 
the whole blood was also observed in all six workers engaged in the clean-up of crystallized 1,3-DNB 
(Okubo and Shigeta 1982). It should be noted however that measurement of specific gravity of blood 
is not common practice and represents an indirect measurement of anemia. No information on 
methemoglobin levels was available. It is important to stress that pathological effects (cyanosis due to 
methemoglobin formation) observed after exposure to 1,3-DNB in one system can be manifested as 
symptoms in another. Other limitations of this study include lack of information on 1,3-DNB 
concentration in the air and the fact that data were collected 10 days after exposure. No long-term 
adverse effects were noted in any of the workers that were followed for up to 10 years after exposure 
to 1,3-DNB. 
No studies were located regarding hematological effects in animals after inhalation exposure to 
1,3-DNB or 1,3,5-TNB. 
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Hepatic Effects. No studies were located regarding hepatic effects in humans after inhalation 
exposure to 1,3,5-TNB. Data on the effects of 1,3-DNB on the liver are inconclusive. Serum 
glutamic-oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic transaminase (SGPT) levels in 
humans were within normal limits after a single acute exposure to 1,3-DNB (Okubo and Shigeta 
1982). Bilirubin was found in the urine of all workers who were strongly positive for urobilinogen 
indicating an unspecified degree of hepatobiliary disease. This study is limited by the fact that there 
are no data on the concentration of 1,3-DNB in the air. 
No studies were located regarding hepatic effects in animals after inhalation exposure to 1,3-DNB or 
1,3,5-TNB. 
Renal Effects. No studies were located regarding renal effects in humans after inhalation exposure 
to 1,3,5-TNB. Elevated levels of urobilinogen were found in all workers exposed to 1,3-DNB 
indicating hemolysis (Olcubo and Shigeta 1982). Limitations of the study are that data were collected 
10 days after exposure and information is lacking on the dose of 1,3-DNB. 
No studies were located regarding renal effects in animals after inhalation exposure to 1,3-DNB or 
1,3,5-TNB. 
2.2.1.3 Immunological and Lymphoreticular Effects 
No studies were located regarding immunological effects in humans or animals after inhalation 
exposure to 1,3-DNB or 1,3,5-TNB. 
2.2.1.4 Neurological Effects 
No studies were located regarding neurological effects in humans after inhalation exposure to 
1,3,5-TNB. Limited information is available regarding the neurological effects of 1,3-DNB. Slight 
headache, nausea, dizziness, and fatigue were the symptoms reported in workers after inhalation 
exposure to 1,3-DNB (Okubo and Shigeta 1982). These symptoms diminished gradually, and the 
recovery period was different in each worker. No long-term effects due to inhalation exposure to 
1,3-DNB were found in any of the workers for up to 10 years after exposure. 
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No studies were located regarding neurological effects in animals after inhalation exposure to 1,3-DNB or 
1,3,5-TNB. 
No studies were located regarding the following health effects in humans or animals after inhalation 
exposure to 1,3-DNB or 1,3,5-TNB: 
2.2.1.5 Reproductive Effects 
2.2.1.6 Developmental Effects 
2.2.1.7 Genotoxic Effects 
Genotoxiciey studies are discussed in Section 2.4. 
2.2.1.8 Cancer 
No studies were located regarding cancer effects in humans or animals after inhalation exposure to 
1,3-DNB or 1,3,5-TNB. 
2.2.2 Oral Exposure 
2.2.2.1 Death 
No studies were located regarding death in humans after oral exposure to 1,3-DNB or 1,3,5-TNB. 
The oral LD50 values for 1,3,5-TNB and 1,3-DNB in rats were 275 mg/kg and 59 mg/kg, respectively 
(Desai et al. 1991); no further details were provided in that abstract. The oral LD50 value for 
1,3-DNB in adult male and female Carworth Farms rats was 91 mg/kg and 81 mg/kg, respectively 
(Cody et al. 1981). Increased mortality in Sprague-Dawley rats (Linder et al. 1990) and rabbits (Parke 
1961) was observed at 48 and 100 mg/kg/day, respectively. The age of the animals appeared to 
influence the acute toxicity of 1,3-DNB, the older animals appearing more susceptible to general 
toxicity than younger animals (Linder et al. 1990). Increased mortality was observed in prepubertal 
mice treated with 40 mg/kg/day (Evenson et al. 1989a). Decreased survival in animals consuming 
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1,3-DNB for 11 weeks exhibited an increase in mortality at 6 mg/kg/day (Linder et al. 1986). At 
slightly a higher doses of 1,3-DNB (12-14 mg/kg/day), increased mortality in rats (Carworth Farms) 
occurred between weeks 4 and 7 (Cody et al. 1981). These results indicate that there may be a 
difference in susceptibility to 1,3-DNB toxicity associated with the age of animals. 
The LD50 value and all reliable LOAEL values for death in each species and duration category are 
recorded in Table 2-1 and plotted in Figure 2-1. 
2.2.2.2 Systemic Effects 
The highest NOAEL value and all reliable LOAEL values for systemic effects in each species and 
duration category are recorded in Table 2-1 and plotted in Figure 2-1. 
Respiratory Effects. The only information regarding respiratory effects of 1,3-DNB or 1,3,5-TNB 
in humans is that of a man who swallowed 30-40 mL of a varnish containing a nitrobenzene dye 
(Kumar et al. 1990). Upon admission to the hospital he was comatose and his breathing was described 
as very shallow. This breathing pattern may have been indirectly caused by a significant increase in 
methemoglobin. 
Data in animals are limited to a report in which no histopathologic alterations were seen in the lungs 
of rats given up to 3 mg/kg/day 1,3-DNB for 16 weeks or 14 mg/kg/day for 8 weeks in the drinking 
water (Cody et al. 1981). 
Cardiovascular Effects. The only information available regarding cardiovascular effects in 
humans is that from a case report in which low blood pressure (80154 mm Hg) and tachycardia 
(160 beats per minute) were observed in a man shortly after he swallowed 30-40 mL of a varnish 
containing a nitrobenzene dye (Kumar et al. 1990). After gastric lavage, his blood pressure increased 
to 100/70 mm Hg and his heart rate decreased to 120 beats per minute. Blood pressure further 
increased to 106/74 and heart rate decreased to 99 beats per minute following an intravenous injection 










23 1,3-DNB AND 1,3,5-TNB 
2. HEALTH EFFECTS 
Information in animals is restricted to a single intermediate-duration study in rats in which no 
histopathologic alterations were observed in the heart and aorta of rats given up to 3 mg/kg/day 
1,3-DNB for 16 weeks or 14 mg/kg/day for 8 weeks in the drinking water (Cody et al. 1981). 
No studies were located regarding the cardiovascular effects in humans or animals after oral exposure 
to 1,3,5-TNB. 
Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in humans 
after oral exposure to 1,3-DNB or 1,3,5-TNB. 
No histopathologic alterations were observed in the stomach, duodenum-pylorus, ileum, and colon of 
rats administered up to 3 mg/kg/day 1,3-DNB for 16 weeks or 14 mg/kg/day for 8 weeks in the 
drinking water (Cody et al. 1981). No further data were located regarding 1,3-DNB and no 
information was available regarding 1,3,5-TNB. 
Hematological Effects. No studies were located regarding hematological effects in humans after 
oral exposure to 1,3,5-TNB. 
The primary effect of 1,3-DNB absorbed into blood is the formation of methemoglobin. For a detailed 
discussion on the mechanism of methemoglobinemia induction please see Section 2.3.5. 
The only information regarding hematological effects of 1,3-DNB in humans is that of a man who 
swallowed 30-40 mL of nitrobenzene dye and was admitted to the hospital with peripheral and central 
cyanosis (Kumar et al. 1990). Evidence of hemolytic anemia was present. Methemoglobin was 37.2% 
after gastric lavage was performed, and was reduced to 5.7% after two injections of methylene blue. 
No studies were located regarding hematological effects in animals after oral exposure to 1,3,5-TNB. 
In acute-duration studies in rats treated with 1,3-DNB, cyanosis was the first sign of acute toxicity and 
deficient blood oxygenation. The exposure doses in rats ranged from 16 to 180 mg/kg (Blackbum et 
al. 1988; Cody et al. 1981; Linder et al. 1988, 1990; Philbert et al. 1987b; Reader et al. 1991). In 
general, the effect was readily reversed when treatment with 1,ZDNB was discontinued. Mice treated 
once with up to 48 mg/kg 1,3-DNB did not appear to develop cyanosis, but the scope of this study 
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was primarily the assessment of reproductive end points and not hematological parameters (Evenson et al. 
1989a). 
When rats were exposed to low doses (0.4-3.1 mg/kg/day) of 1,3-DNB for 16 weeks, no overt signs 
of acute toxicity were seen (Cody et al. 1981). There was, however, a moderate decrease in 
hemoglobin levels after weeks 5 and 10, but they returned to control levels by week 14 (Cody et al. 
1981). Splenic hemosiderosis was observed in all groups of rats treated with 0.75-6 mg 1,3-DNB by 
gavage for 12 weeks, including controls (Linder et al. 1986). Splenic hemosiderosis, which was 
minimal in controls and moderate to moderately severe at the highest dose level, is consistent with 
hemolytic anemia. No chronic-duration studies were located. 
Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans 
after oral exposure to 1,3-DNB or 1,3,5-TNB. 
Information in animals is limited to a study in which no histopathologic alterations were observed in 
skeletal muscle (unspecified) of rats given up to 3 mg/kg/day 1,3-DNB for 16 weeks or 14 mg/kg/day 
for 8 weeks in the drinking water (Cody et al. 1981). No information was located regarding 
1,3,5-TNB. 
Hepatic Effects. No studies were located regarding hepatic effects in humans after oral exposure 
to 1,3-DNB or 1,3,5-TNB. 
No histopathological alterations were seen in the liver of rats treated with up to 3 mg/kg/day 1,3-DNB 
for 16 weeks or 14 mg/kg/day for 8 weeks in the drinking water (Cody et al. 1981). No information 
was available regarding 1,3,5-TNB. 
Renal Effects. No studies were located regarding renal effects in humans after oral exposure to 
1,3-DNB or 1,3,5-TNB. 
Only one study was located that examined the effect of 1,3-DNB on the kidneys (Cody et al. 1981). 
In that study, no histopathologic alterations were observed in the kidneys of rats administered up to 
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3 mg/kg/day 1,3-DNB for 16 weeks or 14 mg/kg/day for 8 weeks in the drinking water. No 
information was located regarding 1,3,5-TNB. 
Endocrine Effects. Levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), 
prolactin (Prl), hypothalamic gonadotropin releasing hormone (GnRH), testosterone, and 
androgenbinding protein (ABP) were evaluated in male Sprague-Dawley rats from 3 hours to 2 weeks 
after treatment with a single oral dose of 32 mg/kg 1,3-DNB (Rehnberg et al. 1988). 
Pituitary weights and weights of androgen-dependent accessory sex organs did not differ in treated 
animal as compared to the controls at any time point. Serum and pituitary levels of LH and Prl were 
not affected by I,3-DNB treatment at any time point examined. FSH concentration in serum was 
significantly higher 2 weeks after treatment, while pituitary FSH levels remained unchanged. These 
results led the investigators (Rehnberg et al. 1988) to suggest that 1,3-DNB exerts a direct effect on 
the testes and not through alterations in hypothalamic and pituitary control of gonadal function. No 
significant changes in pituitary weight were observed over a 14-day period in male rats exposed to a 
single oral dose of 8-48 mg/kg 1,3-DNB (Linder et al. 1990). 
In intermediate-duration studies, no histopathologic alterations were observed in the pancreas, thyroids, 
adrenals, and pituitary of rats given up to 14 mg/kg/day 1,3-DNB for 8 weeks or 3 mg/kg/day 
1,3-DNB for 16 weeks in the drinking water (Cody et al. 1981). Administration of up to 6 mg/kg/day 
1,3-DNB by gavage for 12 weeks to rats did not result in alterations of the adrenal’s weight (Linder et 
al. 1986). No further endocrine end point was assessed in the latter study. 
Dermal Effects. No studies were located regarding dermal effects in humans after oral exposure to 
1,3-DNB or 1,3,5-TNB. 
Data in animals are provided by only one intermediate-duration study in rats (Cody et al. 1981). In 
that study, the investigators reported that no histopathological alterations were observed in the skin of 
rats given up to 3 mg/kg/day 1,3-DNB for 16 weeks or 14 mg/kg/day for 8 weeks in the drinking 
water. No data were available for 1,3,5-TNB. 
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Ocular Effects. No studies were located regarding ocular effects in humans after oral exposure to 
1,3-DNB or 1,3,5-TNB. 
Very little information was available regarding ocular effects in animals. Exophthalmia was observed 
in rats given a single lethal dose of 1,3-DNB (Cody et al. 1981). This effect, according to the 
investigators, appeared to reflect a condition of general congestion prior to death. In an 
intermediateduration study (Cody et al. 1981), no histopathologic alterations were observed in the eyes of 
rats treated with up to 14 mg/kg/day 1,3-DNB for 8 weeks or 3 mg/kg/day for 16 weeks in the drinking 
water. No data were found regarding 1,3,5-TNB. 
Body Weight Effects. No studies were located regarding body weight effects in humans after oral 
exposure to 1,3-DNB or 1,3,5-TNB. 
In an acute-duration study, male Sprague-Dawley rats treated with a single dose of 848 mg/kg 
1,3-DNB and examined over a 32-day period did not show significant decreases in body weight 
(Evenson et al, 1989b). In addition, the same group of investigators (Evenson et al. 1989a) noted no 
significant differences in body weight between treated and control groups of adult and pubertal 
(26 days old) male mice exposed to a single oral dose of 8-48 mg/kg 1,3-DNB. No significant 
changes in body weight were noted in male rats exposed to a single oral dose of 8-48 mg/kg 1,3-DNB 
and observed for 14 (Linder et al. 1990) or 175 days (Linder et al. 1988). 
A significant reduction in body weight gain was noted in male and female rats exposed for 8. weeks to 
4.7 and 6 mg/kg/day 1,3-DNB, respectively, via drinking water (Cody et al. 1981). Higher doses, 
12.5 mg/kg/day in males and 14.4 mg/kg/day in females, induced frank weight loss (Cody et al. 1981). 
In another study by the same group of investigators (Cody et al. 1981), female rats exposed to 
3 mg/kg/day in the drinking water for 16 weeks had a reduced rate of growth after 8 weeks and, at the 
end of 16 weeks, weight was significantly lower than for control females; growth rate of males was 
not affected by treatment with 1,3-DNB. Also, male rats treated by gavage with 6 mg/kg/day 
1,3-DNB for 12 weeks experienced a significant decrease (16%) in body weight during a breeding 
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2.2.2.3 Immunological and Lymphoreticular Effects 
No studies were located regarding immunological effects in humans after exposure to 1,3-DNB or 
1,3,5-TNB. 
Splenic enlargement and congestion, and increased erythropoietic activity were observed in the spleen 
from male rats (females were not tested) treated’ with a single dose of 15 or 25 mg/kg 1,3-DNB and 
sacrificed at various intervals (2-96 hours) after dosing (Blackbum et al. 1988). This, however, is 
most likely an extramedullary response and is consistent with hemolytic anemia. 
In intermediate-duration studies, spleen enlargement occurred in male and female rats treated with 
approximately 1 mg/kg/day 1,3-DNB in the drinking water for 16 weeks (Cody et al. 1981). Similar 
results were reported in rats administered 1.5 mg/kg/day 1,3-DNB by gavage for 12 weeks (Linder et 
al. 1986). Treatment of rats with doses of about 12-14 mg/kg/day 1,3-DNB in the drinking water for 
8 weeks induced hemosiderin deposits in the spleen and spleen atrophy and fibrosis (Cody et al. 
1981). No data were located for 1,3,5-TNB. 
All reliable LOAEL values for immunological effects in each species and duration category for 
1,3-DNB are recorded in Table 2-l and plotted in Figure 2-l. 
2.2.2.4 Neurological Effects 
The only information available regarding neurological effects in humans comes from a case report of
 
an accidental poisoning of a man who swallowed varnish containing nitrobenzene dye and was
 
admitted to the hospital in a deep coma. Based on the known properties of nitrobenzenes in general,
 
the development of coma may have been secondary to methemoglobinemia (37.2%) and cyanosis.
 
No studies were located regarding neurological effects in animals after oral exposure to 1,3,5-TNB.
 
Physical signs of neurotoxicity following acute-duration exposure to 1,3-DNB were manifested in slow
 
movement, loss of movement, loss of equilibrium, and general hypoactivity in rats given single oral doses
 
of 1,3-DNB ranging from 20 to 48 mg/kg (Linder et al. 1988, 1990; Philbert et al. 1987b).
 
Older adult rats seemed to be more susceptible to neurotoxicity following a single dose of 48 mg/kg of
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Studies of intermediate duration evaluating neurological effects are inconclusive. Administration of 
6 mg/kg/day 1,3-DNB by gavage to male Sprague-Dawley rats (females not tested) for 12 weeks 
caused severe neurotoxic effects (impaired movement, paresis, loss of equilibrium, and muscle rigidity) in 
all animals (Linder et al. 1986). In another study, the activity level of male Cat-worth Farms rats (females 
not tested) given 0.4 and 1.1 mg/kg/day 1,3-DNB in drinking water for 16 weeks was measured with both 
activity wheels and activity platforms (Cody et al. 1981). In both treated groups, there was a significant 
increase in activity wheels relative to controls, but activity in platforms was not significantly greater than 
the level of activity of the control group. The same group of investigators (Cody et a!. 1981) found no 
histopathologic alterations in the brain and spinal cord from rats given up to 3 mg/kg/day 1,3-DNB for 16 
weeks or 14 mg/kg/day for 8 weeks. 
All reliable LOAEL values for neurological effects in each species and duration category for 1,3-DNB 
are recorded in Table 2-1 and plotted in Figure 2-1. 
2.2.2.5 Reproductive Effects 
No studies were located regarding reproductive effects in humans after oral exposure to 1,3-DNB or 
1,3,5-TNB. 
No studies were located regarding reproductive effects in animals after oral exposure to 1,3,5-TNB. 
Reproductive toxicity in the form of reduced testes and epididymis weight was consistently observed 
in rats exposed to a single oral dose (ranging from 25 to 50 mg/kg) of 1,3-DNB (Blackbum et al. 
1988; Evenson et al. 1989a; Linder et al. 1988; Rehnberg et al. 1988). Reduced testicular weight was 
observed in two groups of adult Sprague-Dawley rats-younger and older animals-after a single 
24 mg/kg dose of 1,3-DNB (Linder et al. 1990). However, older adult rats were more sensitive to 
1,3-DNB-induced toxicity. Epididymal weight, testicular sperm head count, and cauda sperm reserves 
in older rats treated with 16 mg/kg of 1,3-DNB were all significantly lower than controls (Linder et al. 
1990). In another study, male Sprague-Dawley rats (3-5/group) were given a single oral dose of 
1,3-DNB in 1.5% dimethyl sulfoxide (DMSO) in corn oil at 0, 12, 30, or 60 mg/kg; animals were 
sacrificed 48 hours later (Moore et al. 1992). The lowest dose had no effect on the testis. At 
30 mg/kg, degeneration and depletion of some of the late pachytene spermatocytes (phagocytosis and 
exfoliation) were observed. At 60 mg/kg, all of the pachytene spermatocytes and round spermatids 
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manner. Based on the finding that urinary creatine was significantly increased at 60 mg/kg in the 
24-hour period following dosing (a period consistent with Sertoli cell damage), the authors (Moore et 
al. 1992) concluded that a substantial proportion of testicular creatine is associated with the cells of the 
seminiferous epithelium and that creatinuria may serve as a marker for damage to these cells. 
In contrast to these findings in .rats are observations made in prepubertal mice that testicular growth 
and development were not affected by 40 or 48 mg/kg of 1,3-DNB (Evenson et al. 1989a). In 
pubertal and adult mice, however, abnormal spermatogenesis and an increase in chromatin structure 
abnormality were apparent after a single dose of 48 mg/kg 1,3-DNB (Evenson et al. 1989a). 
Testicular histopathology revealed that major early changes after exposure to 1,3-DNB consisted of 
degeneration of germinal epithelium and sloughing of both spermatocytes and spermatids which in turn 
resulted in reduced sperm counts and reduced sperm mobility (Blackbum et al. 1988; Evenson et al. 
1989b; Linder et al. 1988, 1990; Reader et al. 1991). Disrupted spermatogenesis was also evidenced by a 
decrease in the number of seminiferous tubules in rats treated with 48 mg/kg of 1,3-DNB (Hess et al. 
1988). At 5 weeks, these changes caused decreased fertilizing ability of spermatozoa and 91% of treated 
rats lost their fertilizing capability (Linder et al. 1990). However, these changes were partially reversible 
since at 5 months after exposure only 18% of rats had not recovered their reproductive capability (Linder 
et’al. 1990). 
An indication that Sertoli cells may be targets in the seminiferous epithelium for early damage by 
1,3-DNB came with the observatton of significantly increased levels of androgen-binding protein 
(ABP, released from Sertoli cells) in.seminiferous tubule fluid, interstitial fluid, and serum in rats 
treated with 15 and 32 mg/kg of 1,3-DNB, respectively (Reader et al. 1991; Rehnberg et al. 1988). 
Further examination of early toxic effects of 15 mg/kg of 1,3-DNB revealed vacuolization and 
cytoplasmic retraction in Sertoli cells within the first 24 hours after exposure (Blackbum et al. 1988). 
Similar observations of Sertoli cell damage were made when 1,3-DNB was administered at a dose of 
30 mg/kg (Reader et al. 1991). Data from these studies support the notion that Sertoli cells may be 
first and primary targets of the toxic effects of I,3-DNB in seminiferous epithelium. 
Plasma hormones and enzymes of testicular origin were used as markers for evaluation of acute 
testicular toxicity in rats treated with 1,3-DNB. Lactate dehydrogenase isozyme C4 (LDHC4) and 
ABP were both elevated after treatment with doses between 10 and 25 mg/kg of 1,3-DNB (Reader et 
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al. 1991). Testosterone levels were reduced after treatment with 10 and 32 mg/kg of 1,3-DNB (Reader 
et al. 1991; Rehnberg et al. 1988). 
Adverse reproductive effects were also observed in rats exposed to 1,3-DNB in intermediate-duration 
studies. Significantly decreased spermatogenesis and atrophy of seminiferous tubules were observed 
after 12 weeks of treatment with 3 mg/kg/day 1,3-DNB by gavage (Linder et al. 1986). Testicular 
atrophy was also observed at 4.7 mg/kg/day after 8 weeks of treatment with 1,3-DNB in the drinking 
water (Cody et al. 1981). A slightly lower dose, 2.64 mg/kg/day, given for 16 weeks induced a 
decrease in testes weight and decreased spermatogenesis (Cody et al. 1981). 
In female rats, administration of up to 3 mg/kg/day 1,3-DNB in drinking water for 16 weeks or up to 
14 mg/kg/day for 8 weeks caused no significant alterations in the weight or histopathologic appearance of 
the ovaries (Cody et al. 1981). 
The highest NOAEL values and all reliable LOAEL values for reproductive effects in animals after 
acute- or intermediate-duration oral exposure are recorded in Table 2-l and plotted in Figure 2- 1. 
2.2.2.6 Developmental Effects 
No studies were located regarding developmental effects in humans or animals after oral exposure to 
1,3-DNB or 1,3,5-TNB. 
2.2.2.7 Genotoxic Effects 
No studies were located regarding genotoxic effects in humans or animals after oral exposure to 
1,3-DNB or 1,3,5-TNB. 
Genotoxicity studies are discussed in Section 2.4. 
2.2.2.8 Cancer 
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2.2.3 Dermal Exposure 
Human studies presented in the section on dermal exposure are reports of accidental occupational 
exposure and one volunteer case study. Since precise levels of exposure in these studies are not 
known, the results in this section are not presented in a table. 
2.2.3.1 Death 
No studies were located regarding death, in humans after dermal exposure to 1,3-DNB or 1,3,5-TNB. 
In an early study, a single dermal application of an ointment containing 25% 1,3-DNB to 3 cats 
resulted in the death of a female cat 12 hours after dosing (White and Hay 1901). Limitations of this 
study include small sample size and lack of information on the amount applied. Information located in 
an abstract indicates that the derrnal LD50 for 1,3-DNB in rabbits was 1,990 mg/kg, and that a dose of 
2,000 mg/kg 1,3,5-TNB was not toxic when applied for 24 hours to the skin of rabbits, but no further 
details were provided (Desai et al. 1991). 
2.2.3.2 Systemic Effects 
No studies were located regarding respiratory, gastrointestinal, or musculoskeletal, effects in humans or 
animals after dermal exposure to 1,3-DNB or 1,3,5-TNB. 
Cardiovascular Effects. The only information available is the case of an investigator who selfapplied 
an amount of ointment containing 100 mg 1,3-DNB three times over a 24-hour period (White 
and Hay 1901). After the third application, he noticed that his heart rate had increased to about 
100-120 beats per minute and did not return to pre-exposure rate (not specified) until 3 days later. No 
further information was provided. 
Hematological Effects. No studies were located regarding hematological effects in humans after 
dermal exposure to 1,3,5-TNB. Limited information is available regarding hematological effects in 
humans after dermal exposure to 1,3-DNB. The case of an investigator who self-applied an amount of 
ointment containing 100 mg of 1,3-DNB 3 times over a 24-hour period is described in an early study 
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were blue. After the third application, cyanosis was evident; he recovered three days later. 1,3-DNB 
is easily absorbed through skin when in aqueous solution (Ishihara et al. 1976) and its main effect is 
induction of methemoglobin formation. A female worker who handled electronics parts immersed in a 
chemical mixture containing 0.5% weight-to-weight (w/w) 1,3-DNB became cyanotic and showed 
signs of anemia upon admission to the hospital 10 days later. The exposure conditions of the above 
case were duplicated with a volunteer worker (Ishihara et al. 1976). Methemoglobin levels reached a 
maximum of 11% four hours after exposure to 1,3-DNB. It was also confirmed that the main 
exposure route was dermal since 1,3-DNB readily permeated latex gloves used to handle immersed 
parts and 1,3-DNB was not detected in the volunteer’s breathing-zone air. The fact that 1,3-DNB 
readily permeated the latex gloves used for protection has enormous implications in the occupational 
setting because it shows that this kind of protection is ineffective. Limitations of this study include 
small sample size, concomitant exposure to other chemicals, and lack of complete information on 
exposure dose. 
No studies were located regarding hematological effects in animals after dermal exposure to 
1,3,5-TNB. In one of the earliest reports on 1,3-DNB exposure, an ointment containing 25% (w/w) 
1,3-DNB was applied to the backs of 3 cats (White and Hay 1901). All three developed classical 
symptoms of methemoglobinemia and cyanosis. 
Methemoglobinemia also was observed in guinea pigs when a solution containing 0.5% (w/w) 
1,3-DNB in a mixture of solvents characterized as water soluble was applied for 4 hours (Ishihara and 
Ikeda 1979). Methemoglobinemia did not develop when the solvent mixture contained less than 
77.5% (w/w) ethylene glycol. 
Hepatic Effects. No studies were located regarding hepatic effects in humans after dermal 
exposure to 1,3,5-TNB. In one case report of occupational exposure to 1,3-DNB (Ishihara et al. 1976), 
the exposed worker had palpable liver while her liver function tests were negative. This study is 
limited in that only a single case was described and functional tests were performed 10 days after the 
exposure. 
No studies were located regarding hepatic effects in animals after dermal exposure to 1,3,5-TNB. In 
one of the earliest studies with 1,3-DNB, the investigators indicate that necropsy of a cat (1 out of 3) 
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to which an ointment containing 25% (w/w) 1,3-DNB was applied 8 days earlier showed fatty 
degeneration in the liver (White and Hay 1901). No further information was provided. 
Renal Effects. No studies were located regarding renal effects in humans after dermal exposure to 
1,3-DNB or 1,3,5-TNB. 
Kidney inflammation was reported in a cat (1 out of 3) that received two applications of an ointment 
containing 25% (w/w) 1,3-DNB over a lo-day period (White and Hay 1901). According to the, 
investigators (White and Hay 1901), this was probably due to toxic nephritis. No further information 
was provided. 
Dermal Effects. No studies were located regarding dermal effects of 1,3-DNB or 1,3,5-TNB in 
humans. 
Data in animals are limited to a study in which no irritation was observed in the skin of guinea pigs 
after application of a formulation containing 0.5% 1,3-DNB (w/w) for 4 hours (Ishihara and Ikeda 
1979). Data located in an abstract indicate that neither 1,3-DNB nor 1,3,5-TNB caused skin irritation 
when applied to the skin of rabbits, but no further details were provided (Desai et al. 1991). 
Ocular Effects. No studies were located regarding ocular effects of 1,3-DNB or 1,3,5-TNB in 
humans. 
Limited information was presented in an abstract indicating that 1,3-DNB caused mild eye irritation in 
rabbits, whereas 1,3,5-TNB caused severe irritation; no further details were provided (Desai et al. 
1991). 
2.2.3.3 Immunological and Lymphoreticular Effects 
No studies were located regarding immunological effects in humans after dermal exposure to 1,3-DNB 
or 1,3,5-TNB. 
Limited data located in an abstract indicate that 1,3-DNB was not a skin sensitizer in guinea pigs, but 
1,3,5-TNB caused a mild allergic reaction; no further details were provided (Desai et al. 1991). 
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2.2.3.4 Neurological Effects 
No studies were located regarding neurological effects in humans after dermal exposure to 1,3,5-TNB. 
Very limited information is available regarding the neurological effects of 1,3-DNB. Headache 
(presumably of vascular origin) and general malaise were reported in a female w.orker who handled 
electronics parts immersed in a chemical mixture containing 0.5% (w/w) 1,3-DNB (Ishihara et al. 
1976). Limitations of this study include small sample size, concomitant exposure to other chemicals, 
and lack of complete information on dose and duration of exposure. 
No studies were located regarding neurological effects in animals after dermal exposure to 1,3-DNB or 
1,3,5-TNB. 
No studies were located regarding the following health effects in humans or animals after dermal 
exposure to 1,3-DNB or 1,3,5-TNB: 
2.2.3.5 Reproductive Effects 
2.2.3.6 Developmental Effects 
2.2.3.7 Genotoxic Effects 
Genotoxicity studies are discussed in Section 2.4. 
2.2.3.8 Cancer 
No studies were located regarding cancer effects in humans or animals after dermal exposure,to 
1,3-DNB or 1,3,5-TNB. 
2.3 TOXICOKINETICS 
Data regarding the toxicokinetics of 1,3-DNB or 1,3,5-TNB in humans are limited to information 
derived from two occupational studies and from a report in which the experimenter self-administered 
1,3-DNB. These data provide qualitative evidence that 1,3-DNB may be absorbed in humans by the 
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in humans. In animals, 1,3-DNB is rapidly absorbed by the oral route;. data from one study indicate 
that at least 70% of a single oral dose was absorbed. In animals, depending on the vehicle, 1,3-DNB 
can also be readily absorbed through the skin. It appears that polar vehicles facilitate absorption. No 
information was located regarding absorption of 1,3-DNB in animals by the inhalation route or of 
1,3,5-TNB by any route of exposure. The mechanism by which 1,3-DNB and 1,3,5-TNB are 
transported to the tissues is not completely understood, but there is some evidence indicating that 
dinitrobenzenes can penetrate the red blood cell membrane.- No information was located regarding 
distribution patterns for 1,3-DNB or 1,3,5-TNB in humans for any route of exposure or in animals 
after inhalation or dermal exposure. The metabolism of 1,3-DNB in animals include both oxidative 
and reductive biotransformations, followed by conjugation. No information is available regarding 
metabolism in humans. Following oral exposure, the main route of excretion of 1,3-DNB metabolites 
.in animals is the urine. This also seems to be the case for humans after de’rmal exposure. No data 
were located regarding excretion of 1,3-DNB or metabolites after inhalation and oral exposure in 
humans or after inhalation and dermal exposure in animals. The toxicity of 1,3-DNB is related to its 
methemoglobin forming capacity in the red blood cells. A reactive metabolic intermediate has been 
.postulated as the responsible agent for the toxicity to the male reproductive organs, but the exact 
mechanism has not been elucidated. 
2.3.1 Absorption 
2.3.1.1 Inhalation Exposure 
Studies undertaken specifically to evaluate absorption of either 1,3-DNB or 1,3,5-TNB in humans after 
an inhalation exposure were not located. However, a study of an occupational exposure to 1,3-DNB 
showed that workers developed cyanosis within the first 24 hours after exposure (Okubo and Shigeta 
1982). Inhalation was considered the major exposure pathway since skin contact was with 1,3-DNB in 
solid form. There was no information, however, on the amount of 1,3-DNB present in the air or on 
the amount of particulate 1,3-DNB deposited on the workers’ skin. 
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2.3.1.2 Oral Exposure 
There-are no quantitative data that describe the absorption of 1,3-DNB or 1,3,5-TNB following oral 
exposure in humans. 
Limited information was located regarding quantitative absorption of 1,3-DNB in animals after oral 
exposure. Rabbits treated with randomly labeled 14C-1,3-DNB in arachis oil in singles doses of 
50-100 mg/kg excreted 65-93% of the administered radioactivity in the urine within 2 days of dosing 
(Parke 1961). This indicated that at least that amount was absorbed from the gastrointestinal tract; 
Similar results were reported in rats in which excretion data suggested that at least 63% of a single 
oral dose was absorbed (Nystrom and Rickert 1987). Further evidence that 1,3-DNB is readily 
absorbed by the oral route is provided by the many studies which examined the toxicological effects of 
this compound administered orally (see Section 2.2.2). No information was located regarding 
1,3,5-TNB. 
2.3.1.3 Dermal Exposure 
No studies were located regarding absorption of 1,3,5-TNB following dermal exposure in humans. 
Data are very limited regarding absorption of 1,3-DNB following dermal exposure in humans. 
Evidence of dermal absorption was found in an early report in which an experimenter became cyanotic 
after self-applying an ointment containing 25% (w/w) 1,3-DNB (White and Hay 1901). Similar 
findings were described in a case of .a woman exposed to a solution containing 0.5% (w/w) 1,3-DNB 
at work and in a male volunteer (Ishihara et al. 1976). 
No studies were located regarding absorption of 1,3,5-TNB following dermal exposure in animals. 
The role that the solvent mixture plays in the absorption of 1,3-DNB was investigated in Hartley 
guinea pigs exposed to solutions of varying composition, but each containing 0.5% (w/w) 1,3-DNB 
(Ishihara and Ikeda 1979). The solvents were ethylene glycol and diethylene glycol at various 
concentrations, along with two different co-existing solutes, ammonium adipate and ammonium 
sebacate (Ishihara and Ikeda 1979). Animals were sacrificed immediately after a 4-hour dermal 
exposure. The animals that received 1,3-DNB in a solvent mixture containing 77.5% (w/w) or more 
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of ethylene glycol developed methemoglobinemia. Methemoglobinemia did not occur when the 
solvent mixture contained less than 77.5% ethylene glycol. Six dicarboxylic acids were also tested as 
co-existing solutes and only two, malonic and adipic acid in the presence of ,ethylene glycol and 
diethylene glycol, were able to induce methemoglobin formation. These two acids were also more 
water soluble than others and allowed water impregnation of stratum corneum by ethylene glycol. The 
authors suggested that the increased water content of stratum comeum in the presence of higher 
concentrations of ethylene glycol may enhance dermal absorption of 1,3-DNB (Ishihara and Ikeda 
1979). 
2.3.2 Distribution 
2.3.2.1 Inhalation Exposure 
No studies were located regarding the distribution of 1,3-DNB or 1,3,5-TNB following inhalation 
exposure in humans or animals. 
2.3.2.2 Oral Exposure 
No studies were located regarding distribution following oral exposure to 1,3-DNB or 1,3,5-TNB in 
humans. 
Limited information was located regarding distribution of 1,3,5-TNB in animals. 1,3,5-TNB-DNA 
adducts were detected in the spleen of rats one day after being gavaged once with 14C-1,3,5-TNB 
(Reddy et al. 1991). DNA adducts were also found in the stomach and liver three days after dosing. 
Twenty-eight days after treatment, the residual adduct level in the liver and stomach was 25%, 
whereas in the spleen was still 100%. Tissue distribution of 14C after a single oral dose of 25 mg/kg 
of 14C-1,3-DNB was examined in Fischer 344 conventional (C) and germ-free (GF) rats (Philbert et al. 
1987b). The amount of 14C label in whole blood, plasma, pancreas, lungs, liver, kidney, adrenal, 
testis, quadriceps femoris muscle, sciatic nerve, white and brown fat, spinal cord, and brain stem was 
examined and was found to be higher in GF animals. The relative distribution of label in different 
organs was as follows: liver > white fat > brown fat > kidney > sciatic nerve > whole blood > plasma 
> testis > brain stem. The amount of label contained in the liver and brain of GF rats was 20 and 
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importance of gastrointestinal tract microflora in the initial phases of 1,3-DNB biotransformation. The 
study is limited in that there is a lack of information on statistical significance of the data. 
2.3.2.3 Dermal Exposure 
No studies were located regarding distribution of I,3-DNB or 1,3,.5-TNB foIlowing dermal exposure in 
humans or animals. 
2.3.2.4 Other Routes of Exposure 
The administration of 1,3-DNB by the intraperitoneal route allows for almost complete absorption. 
The level of 1,3-DNB in blood was evaluated in rats and hamsters after a single intraperitoneal 
injection of 25 mg/kg of radioactive 1,3-DNB (14C-1,3-DNB) (McEuen and Miller 1991). The peak 
blood concentration of 14C-1,3-DNB was 99.5 nmol/mL in rats and was reached within 1 hour of 
exposure. Rats had twice the blood level of 14C-1,3-DNB found in hamsters. 
2.3.3 Metabolism 
2.3.3.1 Inhalation Exposure 
No studies were located regarding metabolism following inhalation exposure to 1,3-DNB or 1,3,5-TNB in 
humans or animals. 
2.3.3.2 Oral Exposure 
No studies were located regarding metabolism of 1,3-DNB or 1,3,5-TNB following oral exposure in 
humans. 
Both oxidative and reductive biotransformations, followed by conjugation, have been demonstrated for 
the metabolism of 1,3-DNB in mammals. The metabolism of the three isomeric dinitrobenzenes 
administered as single oral doses to rats (25 mg/kg) has been determined and compared (Nystrom and 
Rickert 1987). Products formed through reduction of the nitro group predominated, and the major 
metabolites were 3-aminoacetanilide (22%), 4-acetamidophenylsulfate (6%), 1,3-diacetamidobenzene 
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 (7%), and 3-nitroaniline-N-glucuronide (4%). These products and their proposed intermediates are 
diagramed in Figure 2-2. 
The metabolism of an oral dose of 50-100 mg/kg 14C-1,3-DNB was followed in rabbits (Parke 1961). 
Of the metabolites detected in urine, 30% were conjugated with glucuronic acid and 6% with sulfate. 
The major urinary metabolites of 1,3-DNB were 2,4-diaminophenol (31%), 1,3-phenylenediamine 
(25%), 1,3-nitroaniline (18%), and 2-amino-4-nitrophenol (14%). Other minor metabolites comprising 
about 20% of the label were oxidation and reduction products and azoxy dimers. 
Several in vitro metabolic studies on 1,3-DNB support the above in viva findings. 1,3-DNB appears 
not to be a substrate for rat hepatic or erythrocyte glutathione transferases (Cossum and Rickert 1985 
1987) since no 1,3-DNB glutathione conjugates were identified. However, the chemical reaction of 
3-nitrosonitrobenzene with glutathione has been shown to form the corresponding hydroxylamino and 
anilino metabolites (Ellis et al. 1992). Studies using rat testicular cells or a co-culture of testicular and 
Sertoli cells showed that 1,3-DNB is metabolized by nitro reduction to 1,3-nitroaniline through 
nitrosonitrobenzene and nitrophenyl hydroxylamine intermediates, without being conjugated to 
glutathione (Cave and Foster 1990; Foster 1989; Lloyd and Foster 1987). 
The relative rates of conversion of 1,3-DNB to nitroanilines were calculated in rat hepatocytes and 
microsomes from the slope of semilogarithmic plots of percentage 1,3-DNB remaining versus time. 
The half-life of 1,3-DNB was estimated to be 12 and 7 minutes in hepatocytes and microsomesi 
respectively, indicating a relatively rapid conversion rate (Cossum and Rickert 1985). 
No studies were located regarding metabolism following oral exposure to 1,3,5-TNB in animals. 
2.3.3.3 Dermal Exposure 
No studies were located regarding metabolism of 1,3,5-TNB following dermal exposure in humans. In 
the only study that measured 1,3-DNB metabolite production in humans after dermal exposure, the 
total production of both amino and nitro metabolites in urine was reported using 2,4-dinitrophenol as a 
standard (Ishihara et al. 1976). The results indicate that 1,3-DNB (in solution) rapidly penetrated skin 
and was also rapidly converted and excreted in urine. A maximum amount of amino and nitro 
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10 hours. The limitations of this study are a small sample size (one person) and no detailed 
information on the nature of 1,3-DNB metabolites. 
No studies were located regarding metabolism of 1,3-DNB or 1,3,5-TNB in animals after dermal 
exposure. 
2.3.3.4 Other Routes of Exposure 
In mammals, the differences in metabolic processing of 1,3-DNB may play an important role in 
susceptibility to toxicity. The metabolism of 1,3-DNB was examined in rats and hamsters after a 
single intraperitoneal injection of 25 mg/kg of 14C-1,3-DNB (McEuen and Miller 1991). Hamsters 
were found to be much less sensitive than rats to the toxic effects of 1,3-DNB. Elimination of 
1,3-DNB from blood was biphasic. The initial rapid phase was followed by a much slower one. 
Maximal blood levels of 1,3-DNB were 46 and 99 nmol/mL in hamsters and rats, respectively. In the 
urine, rats excreted more unconjugated metabolites and less phenolic metabolites than hamsters. The 
presence of unconjugated reductive metabolites in rats may in part be responsible for increased toxicity of 
1,3-DNB. In another study, Sprague-Dawley rats and Syrian hamsters were exposed to increasing 
concentrations of 1,3-DNB. It was found that Syrian hamsters were more resistant to the toxic effects of 
1,3-DNB (Obasaju et al. 1991). At the lowest dose (25 mg/kg), methemoglobin was 15% in hamsters 
compared to 83% in rats. The same was true for testicular damage observed within 
48 hours in rats and absent in hamsters even when the dose was 50 mg/kg. This difference in 
susceptibility to toxic effects between the two species, rats and hamsters, is again probably due to 
differences in metabolism of 1,3-DNB. 
2.3.4 Excretion 
2.3.4.1 Inhalation Exposure 
No studies were located regarding excretion of 1,3-DNB or 1,3,5-TNB after inhalation exposure in 
humans or animals. 
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2.3.4.2 Oral Exposure 
No studies were located regarding excretion following oral exposure to 1,3-DNB or 1,3,5-TNB in 
humans. 
No studies were located regarding excretion following oral exposure to 1,3,5-TNB in animals. 
Following administration of a single oral dose of 14C-1,3-DNB to rabbits and rats, radioactivity 
accounting for more than 80% and 63% of the dose, respectively, was excreted in urine, indicating that 
the main route of excretion is via the urine (Nystrom and Rickert 1987; Parke 1961). Elimination of 
1,3-DNB metabolites in urine was rapid and occurred within 48 hours. The major urinary metabolites 
in rabbits were 2,4-diaminophenol, 1,3-phenylenediamine, and 1,3-nitroaniline (Parke 1961). 
2.3.4.3 Dermal Exposure 
No studies were located regarding excretion of 1,3,5-TNB after dermal exposure in humans. In the 
only study that evaluated 1,3-DNB urinary metabolites in humans after dermal exposure, amino and 
nitro metabolites were reported as a single value using 2,4-dinitrophenol as a standard (Ishihara et al. 
1976). Amino and nitro metabolites reached maximum levels within the 1st hour after exposure and 
returned to normal levels within 10 hours. The results indicate that 1,3-DNB was rapidly absorbed 
through skin and was also rapidly converted and excreted in urine. This study is limited by the small 
sample size (one person) and lack of information on the specific nature of 1,3-DNB metabolites. 
No studies were located regarding excretion following dermal exposure to 1,3-DNB or 1,3,5-TNB in 
animals. 
2.3.4.4 Other Routes of Exposure 
Excretion of 14C-1 ,3-DNB was followed in urine and feces of Sprague-Dawley rats and Syrian 
hamsters after a single intraperitoneal dose of 25 mg/kg (McEuen and Miller 1991). More than 80% 
of the label was excreted in urine by both species within the first 24 hours. Rats needed less time to 
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2.3.5 Mechanisms of Action 
Two major systems have been identified as toxicity targets for 1,3-DNB: the red blood cell and the 
male reproductive system (see Section 2.2.2). In the red blood cell, 1,3-DNB induces formation of 
methemoglobin leading to cyanosis (Blackbum et al. 1988; Linder et al. 1988, 1990; Reader et al. 
1991). In the male reproductive system, 1,3-DNB causes disruption of spermatogenesis resulting in 
hypospermia, poor sperm quality, and infertility (Blackburn et al. 1988; Hess et al. 1988; Linder et al. 
1988). Whether adverse hematological and reproductive effects are caused by the same mechanism of 
action remains unresolved. 
Reduction of the nitrogroup(s) of 1,3-DNB is a reaction that predominates over oxidative pathways in 
mammals. Reduction of the nitro groups produces reactive nitroaromatic radical anions which redox 
cycle to produce other reactive, toxic species such as superoxide anion (Mason and Holzman 1975; 
Wardman and Clarke 1976). Redox cycling of these intermediates probably causes the 
methemoglobinemia associated with exposure to 1,3-DNB (Kiese 1974). Methemoglobinemia is 
defined as a methemoglobin concentration of greater than 1%, and it results from iron in the normal 
ferrous state being oxidized to the ferric state at a rate that exceeds the. erythrocyte’s reducing capacity. 
Methemoglobin is unable to combine reversibly with oxygen and carbon dioxide and also causes a shift in 
the oxygen dissociation curve toward increased oxygen affinity, preventing the transfer of oxygen from 
the blood to the tissues. 
Within the reproductive system the prime target for 1,3-DNB toxicity appears to be the Sertoli cell. 
Results from numerous studies support this hypothesis (Blackbum et al. 1988; Hess et al. 1988; Linder 
et al. 1988). As previously mentioned, some investigators have suggested that testicular damage may 
be related to tissue hypoxia, which results from impaired oxygen transport as a consequence. of 
methemoglobinemia (Linder et al. 1988). It appears, however, that reduction of 1,3-DNB to reactive 
species such as nitrophenylhydroxylamine and nitrosonitrobenzene. are involved in the testicular 
toxicity of 1,3-DNB (Cave and Foster 1990; Ellis and Foster 1992). In studies using rat testicular cells 
or a co-culture of testicular and Sertoli cells, 1,3-DNB was metabolized by nitro reduction to 
1,3-nitroaniline through nitrosonitrobenzene and nitrophenyl hydroxylamine intermediates, without 
being conjugated to glutathione (Cave and Foster 1990; Foster 1989; Lloyd and Foster 1987). Of all 
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those seen with 1,3-DNB when reintroduced into cell cultures (Foster 1989). The specific mechanism 
by which the reactive intermediate might induce cell damage is unknown. 
2.4 RELEVANCE TO PUBLIC HEALTH 
The general population is not likely to be exposed to either 1,3-DNB or 1,3,5-TNB. Exposure to both 
compounds is possible around Army ammunition plants. Occupational or accidental exposure to 
1,3-DNB and 1,3,5-TNB may also occur in industries using these two compounds in manufacturing 
processes (e.g., explosives, plastics, dyes). 
The major effects observed in animals after exposure to 1,3-DNB are methemoglobin formation and 
testicular damage at doses that are higher than 1 mg/kg. Both effects are common to other 
nitroaromatic compounds. The biochemical changes that occur in the blood, primarily methemoglobin 
formation, lead to oxygen deprivation in the tissues, and then to cyanosis and neurotoxicity. 
For the general population, oral exposure to 1,3-DNB and 1,3,5-TNB is the most likely exposure route. It 
can occur through ingestion of contaminated water; however, the solubility of these compounds in water 
is quite low (500 ppm and 3,500 ppm, respectively). Inhalation exposure and dermal exposure to 1,3-
DNB and 1,3,5-TNB present in air are less likely because of their low volatility. 
No deaths have been reported in humans from exposure to either 1,3-DNB or 1,3,5-TNB. Information 
on the effects that occur in humans in response to 1,3-DNB exposure comes from case reports of 
accidental poisoning, from studies of occupationally exposed workers and from a study in which a 
subject self-administered 1,3-DNB for research purposes. 
No information has been located regarding human exposure to 1,3,5-TNB. Acute exposure of humans 
to 1,3-DNB causes symptoms that are the result of increased levels of methemoglobin in the blood 
which in turn causes oxygen deprivation in the tissues. Among the first of these symptoms is 
cyanosis. Other signs of exposure of humans in occupational settings have been associated with mild 
central nervous system intoxication manifested by headaches and general malaise. No studies were 
located regarding chronic exposure to 1,3-DNB in humans. 
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Studies in animals support the observations of the toxic effects in humans. Moreover, results from 
animal studies indicate that other toxic effects could be associated with exposure to 1,3-DNB. These 
include testicular damage, decreased reproductive function, splenomegaly, and/or spleen atrophy. 
Minimal Risk Levels for 1,3-DNB and 1,3,5-TNB. 
Inhalation MRLs. 
No inhalation MRLs were derived for 1,3-DNB or 1,3,5-TNB due to lack of human and animal data. 
Oral MRLs. 
An MRL of 0.08 mg/kg/day has been derived for acute-duration oral exposure (14 days or less) 
to 1,3-DNB. 
The acute oral MRL was based on a NOAEL for testicular toxicity in male rats administered a single 
dose of ≥16 mg 1,3-DNB/kg in corn oil and sacrificed 14 days later (Linder et al. 1990). No adverse 
effects were observed at 8 mg 1,3-DNB/kg. Effects observed at ≥16 mg/kg included substantial 
damage to the testicular germinal epithelium, reduction in epididymal weigh, and decreased number 
and morphological changes in spermatozoa. Histological changes, including luminal debris and 
atypical cells and hypospermia were noted at ≥16 mg/kg. Cyanosis was seen at dose levels 
≥16 mgJkg, and neurotoxicity and increased mortality occurred at 48 mg/kg. These results are 
supported by a number of studies in animals that have identified the male reproductive system as a 
target for 1,3-DNB toxicity (Blackburn et al. 1988; Moore et al. 1992; Reader et al. 1991). 
An MRL of 0.0005 mg/kg/day has been derived for intermediate oral exposure (15-364 days) to 
1,3-DNB. 
The intermediate oral MRL was based on a LOAEL for splenic hemosiderosis in male rats 
administered 0.75 mg/kg/day 1,3-DNB by gavage in acetone/corn oil solution 5 days/week for 
12 weeks (Linder et al. 1986). This dose-related response was minimal in controls and moderate to 
moderately severe at the highest dose level tested, 6 mg/kg/day. Splenic enlargement was also 
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≥1.5 mg/kg/day. Altered spermatogenesis was noted at ≥3 mg 1,3-DNB/kg/day. The observed splenic 
effects are considered secondary to the hematoxicity of 1,3-DNB and are supported by increased 
erythropoietic activity in rats in a study by Blackburn et al. (1988) and hemosiderosis in rats in a study 
by Cody et al. (1981), and are consistent with hemolytic anemia. The hematological effects of 
1,3-DNB are consistent with effects produced by other nitroaromatic compounds, reinforcing the 
toxicological significance. 
No MRL has been derived for chronic oral exposure to 1,3-DNB, or for acute-, intermediate-, or 
chronic-duration oral exposure to 1,3,5-TNB due to lack of data. 
Death. No deaths have been reported in humans from exposure to either 1,3-DNB or 1,3,5-TNB. 
Death has been observed in rats, rabbits, and mice after oral exposure to 1,3-DNB (Cody et al. 1981; 
Evenson et al. 1989a; Linder et al. 1990; Parke 1961). Death has also been reported in rats after oral 
exposure to 1,3,5-TNB (Desai et al. 1991). However, it is unlikely that amounts of 1,3-DNB or 
1,3,5-TNB sufficient to cause death could be ingested by humans from environmental exposures such 
as living close to ammunition plants or those employed in the dyestuffs, plastics, rubber, and other 
industries. 
Systemic Effects. 
Respiratory Effects. Slight dyspnea upon exertion was reported in some of the workers after ah 
inhalation exposure to 1,3-DNB (Okubo and Shigeta 1982). Six factory workers were cleaning 
crystallized 1,3-DNB from a tank and had only gauze masks and rubber gloves for protection. No 
exposure data was available in that study. Shallow breathing was reported in a subject that ingested a 
varnish containing a nitrobenzene dye (Kumar et al. 1990), but this may have been secondary to the 
fact that the subject was in a coma and cyanosis had developed. No studies in animals were found on 
respiratory effects after exposure to 1,3-DNB other than a report in which no histopathologic 
alterations were seen in the lungs of rats exposed orally for 8-16 weeks (Cody et al. 1981). Data were 
not located for 1,3,5-TNB. The information available; although scant, do not seem to indicate that the 
respiratory system is a target for 1,3-DNB or 1,3,5-TNB. 
Cardiovascular Effects. Palpitations, low blood pressure, and tachycardia were described in subjects 
exposed to 1,3-DNB by the inhalation (Oknbo and Shigeta 1982), oral (Kumar et al. 1990), and 
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dermal (White and Hay 1901) routes of exposure. These responses are consistent with effects of 
organic nitrates. 1,3-DNB is an organic nitrate and shares many of the cardiovascular properties of 
therapeutic nitrates. Organic nitrates induce relaxation of the vascular smooth muscle which can result 
in peripheral vasodilation and a fall in blood pressure followed by a compensatory vasoconstriction 
(Abrams 1980). The general information available on organic nitrates suggests that exposure to 
1,3-DNB or 1,3,5-TNB at ammunition waste sites or at work places where these chemicals are used 
may lead to adverse cardiovascular effects. 
Hematdogicd Effects. Induction of methemoglobin formation is one of the first hematological effects 
to occur after exposure to nitrobenzene compounds, including 1,3-DNB, by any route of administration 
(Ishihara et al. 1976; Kumar et al. 1990; Okubo and Shigeta 1982). As a result of oxygen deprivation and 
increased methemoglobin levels, cyanosis becomes apparent within the first 24 hours after exposure 
(White and Hay 1901). The mechanism of methemoglobin formation is discussed in section 2.3.5. After 
exposure to 1,3-DNB, mild-to-moderate anemia may occur and its severity depends on the duration of the 
exposure (Ishihara et al. 1976; Kumar et al. 1990; Okubo and Shigeta 1982). This small number of studies 
indicate that 1,3-DNB causes hematological effects in humans shortly after exposure. Although there are 
no data on high-level or intermediate exposure, it is reasonable to expect that higher levels of 1,3-DNB 
and longer exposure times would cause severe toxic effects. Studies in animals support findings of these 
toxic effects in humans and suggest that metabolic processing of 1,3-DNB plays an important role in 
susceptibility. to hematological effects. For example, an intraperitoneal dose of 25 mg/kg 1,3-DNB 
caused 15% methemoglobin in hamsters compared with 80% in rats (Obasaju et al. 1991). Another study 
found that. after administration of the same. dose of 1,3-DNB to hamsters and rats, blood levels of 1,3-
DNB in hamsters were half those found in rats (McEuen and Miller 1991). Other differences in the 
metabolic disposition of 1,3-DNB between hamsters and rats were that rats had higher blood levels of the 
metabolite nitroaniline and excreted more unconjugated and less phenolic metabolites in the urine 
(McEuen and Miller 1991). All together, these data suggest that metabolic activation may be needed for 
hematotoxicity and that this metabolic activation is species-specific. No information was found regarding 
hematological effects in humans or animals after exposure to 1,3,5-TNB. An intermediate oral MRL was 
derived based on hematological effects in male rats administered 0.75 mg/kg/day 1,3-DNB by gavage for 
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Hepatic Effects. Results of the studies on hepatic effects in humans after exposure to 1,3-DNB are 
inconclusive. In one case report of occupational exposure to 1,3-DNB, the exposed worker had 
palpable liver and jaundice while her liver function tests were negative (Ishihara et al. 1976). This 
study is limited in that it describes only one case and there is no information on the dose. In addition, 
functional tests were performed 10 days after the exposure occurred. In another study, hepatic 
transaminase levels (SGOT and SGPT) were within normal limits after a single acute-duration 
exposure to 1,3-DNB (Okubo and Shigeta 1982). Bilirubin was also found in all urine samples from 
exposed workers who were strongly positive for urobilinogen, indicating an unspecified degree of 
hepatobiliary disease. All exposed workers were followed for 10 years after exposure and showed no 
long-term adverse effects. This study is limited in that there are no data on the dose of 1,3-DNB and 
the functional tests were performed 9 days after exposure. Studies in animals provided little 
information. Exposure of rats to 1,3-DNB for 8 or 16 weeks in the drinking did not result in 
histopathologic alterations in the liver (Cody et al. 1981). Based on the available information and the 
lack of chronic-duration exposure data in humans or animals, it is difficult to estimate whether 
exposure to 1,3-DNB at hazardous waste sites or in industrial settings will lead to adverse hepatic 
effects. No information was found regarding hepatic effects in humans or animals after exposure to 
1,3,5-TNB. 
Renal Effects. Although no adverse effects on renal function have been reported, elevated levels of 
urobilinogen were found in workers after inhalation exposure to an unspecified amount of 1,3-DNB 
(Okubo and Shigeta 1982). It took approximately 50 days for urobilinogen to return to normal .levels. 
The only information located regarding renal toxicity in animals after exposure to 1,3-DNB was from 
an early study in which kidney inflammation was observed in a cat after dermal application of 
1,3-DNB (White and Hay 1901); the dose applied was lethal. Persons exposed to high levels of 
1,3-DNB by any of the three routes may have an increased risk of renal toxicity. It is not clear 
whether chronic exposure to very low levels of 1,3-DNB by any of the three routes might cause renal 
toxicity. 
No studies were located regarding renal toxicity in humans or animals after exposure to 1,3,5-TNB. 
Therefore, it is not known if adverse renal effects would occur following inhalation, oral, or dermal 
exposure to 1,3,5-TNB. 
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Body Weight Effects. No information was located regarding body weight effects in humans after 
inhalation, oral, or dermal exposure to 1,3-DNB or 1,3,5-TNB. One single oral intermediate-duration 
study showed that 1,3-DNB administered in drinking water for 8 weeks can lead to reduced growth 
rate (4-6 mg/kg/day) or even to body weight loss (12-14 mg/kg/day) (Cody et al. 1981). These 
responses could not be explained solely by reduced food consumption, but reduced water intake and 
dehydration may have played a role. The relevance of these findings to effects in humans is difficult 
to ascertain. 
Immunological and Lymphoreticular Effects. No studies were located regarding 
immunological effects in humans after exposure to 1,3-DNB or 1,3,5-TNB. Studies in animals have 
not assessed the immune response after exposure to 1,3-DNB or 1,3,5-TNB, but spleen enlargement 
was reported in rats in acute- (Blackbum et al. 1988) and intermediate-duration (Cody et al. 1981; 
Linder et al, 1986) oral studies. Spleen enlargement, however, was probably a secondary response to 
the methemoglobinemia resulting from 1,3-DNB intake. Results from tests in guinea pigs showed that 
1,3-DNB was not a skin sensitizer and that 1,3,5-TNB was mildly allergenic (Desai et al. 1991). 
Based on the information available, it is not known whether adverse immunological effects would 
occur in humans following inhalation, oral, or dermal exposure to 1,3-DNB or 1,3,5-TNB. 
Neurological Effects. Very limited information is available regarding the neurological effects of 
1,3-DNB. Slight headache, nausea, dizziness, and fatigue were symptoms reported in workers after 
inhalation exposure to 1,3-DNB (Okubo and Shigeta 1982). Headache accompanied a single dermal 
exposure to 1,3-DNB (Ishihara et al. 1976). These symptoms are probably the result of oxygen 
deprivation due to the presence of increased methemoglobin in the blood or to vasodilation of cerebral 
blood vessels. Acute-duration studies in animals have reported ataxia (weakness, loss of balance, 
flaccid paralysis) at doses that induced cyanosis (Cody et al. 1981; Linder et al. 1988, 1990; Philbert 
et al. 1987b). There was also ,a difference in susceptibility to the neurotoxic effects of 1,3-DNB 
between older and younger rats, older adult animals being more sensitive (attributed to reduced 
metabolism of 1,3-DNB) than younger ones (Linder et al. 1990). Results from intermediate-duration 
oral studies provided conflicting data. Ataxia was reported in rats given 6 mg/kg/day 1,3-DNB by 
gavage for 12 weeks (Linder et al. 1986), but neither ataxia nor histopathological alterations in the 
brain or spinal cord were observed in rats treated with 12-14 mg/kg/day 1,3-DNB in drinking water 
for 8 weeks (Cody et al. 1981). The different manner of administering the compound between these 
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seen in rats treated with a relatively low dose (0.4 mg/kg/day) of 1,3-DNB for 90 days in drinking 
water (Cody et al. 1981). This indicates that low 1,3-DNB doses may induce subtle neurological 
effects, which were not assessed in other studies.  The existing information would suggest that adverse 
neurological effects appear at hematotoxic exposure levels. The information available is insufficient to 
determine whether long-term exposure to low levels of 1,3-DNB might affect the nervous system. 
No studies were located regarding neurological effects after exposure to 1,3,5-TNB in humans or 
animals. Therefore, it is not known if inhalation, oral, or dermal exposure to 1,3,5-TNB would cause 
adverse neurological effects. 
Reproductive Effects. Studies in humans have not addressed whether adverse reproductive 
effects occur after exposure to either 1,3-DNB or 1,3,5-TNB. However, adverse reproductive effects 
were observed in male rats, mice, and ‘hamsters (females were not tested) after a single or repeated 
oral administration of 1,3-DNB. The Sertoli cell has been suggested as the prime target for 1,3-DNB 
toxicity (Blackbum et al. 1988; Hess et al. 1988; Reader et al. 1991). Because the Sertoli cells have 
been shown to be involved in the control of spermatogenesis, damage to them could precipitate the 
wide range of effects seen in germ cells (Blackbum et al. 1988). Reduced testes and epididymis 
weights, disruption of spermatogenesis, hypospermia, poor sperm quality, and infertility were 
consistent findings regarding reproductive toxicity (Blackbum et al. 1988; Cody et al. 1981; Evenson 
et al. 1989a; Linder et al. 1986, 1988; Moore et al. 1992; Reader et al. 1991; Rehnberg et al. 1988). 
Susceptibility to reproductive toxicity of 1,3-DNB appears to be different in older and younger animals 
(Linder et al. 1990); the authors suggested that reduced metabolism in older animals led to greater 
bioavailability, implying that the parent compound may be the toxic entity. The specific mechanism 
of 1,3-DNB toxicity has not been elucidated. Some have suggested that testicular damage may be 
related to tissue hypoxia (Linder et al. 1988), which is the result of increased methemoglobin 
formation. 
Different susceptibility among species to reproductive effects seems also related to the metabolism of 
1,3-DNB. Rats were much more susceptible to adverse reproductive effects of 1,3-DNB than hamsters 
(McEuen and Miller 1991; Obasaju et al. 1991). This was correlated with the fact that blood levels of 
1,3-DNB in the hamster reached only half those found in the rat and that blood levels of the 
metabolite 1,3-nitroaniline were higher in the rat (McEuen and Miller 1991). Furthermore, rats 
excreted more unconjugated and less phenolic metabolites than hamsters. Results from studies with rat 
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Sertoli/germ cell cocultures suggest that reactive metabolic intermediates such as nitrosonitrobenzene 
and nitrophenylhydroxylamine may be responsible for the testicular toxicity of 1,3-DNB (Cave and 
Foster 1990). An acute oral MRL was derived based on reproductive effects in male rats treated with 
a single dose of 16 mg/kg 1,3-DNB by gavage (Linder et al. 1990). 
Based on the findings reported in these studies, the possibility of adverse effects occurring in human 
males following exposure to sufficiently high levels of 1,3-DNB cannot be excluded. As stated earlier, 
these higher 1,3-DNB levels are not likely to be present in the vicinity of ammunition plants. 
Developmental Effects. Studies in humans or animals have not investigated whether adverse 
developmental effects occur as a result of exposure to 1,3-DNB or 1,3,5-TNB. Therefore, it is not 
known if inhalation, oral, or dermal exposure to 1,3-DNB or 1,3,5-TNB would cause adverse 
developmental effects. 
Genotoxic Effects. There were no studies available regarding the genotoxicity of 1,3-DNB or 
1,3,5-TNB in either humans or animals in vivo. One study was located that tested the effects of 
1,3-DNB on rat liver cells. No significant increase in deoxyribonucleic acid (DNA) damage was 
observed (Probst et al. 1981). The remaining studies were eithef bacterial or fungal assays for 
mutagenicity, DNA damage, or mitotic recombination. The results for the Salmonella typhimurium 
mutagenicity tests were dependent on the strain of bacteria and test used. Positive responses were 
observed in strains TA98, TA100, TA1538, TA1537, TA1535, and D3052. Since strains TA98, 
TA1538, and TA1537 are sensitive to frameshift mutations and strains TA100 and TA1535 are 
sensitive to base-pair substitutions, positive responses in each of these strains suggest that 1,3-DNB 
produces both types of gene mutations in S. typhimurium (Chiu et al. 1978; Furukawa et al. 1985; 
Gamer and Nutman 1977; Kaden et al. 1979; Kerklaari et al. 1987; McGregor et al. 1980; Melnikow 
et al. 1981; Probst et al. 1981; Shimizu et al. 1983; Spanggord et al. 1982b). Two groups of 
investigators compared mutagenicity results using normal strains and strains deficient in nitroreductase 
(TA100NR or TA100NR3). The results were positive for the normal strains (TA100, TA98, and 
TA1538) but negative for the nitroreductase-deficient strains (Kerklaan et al. 1987; Spanggord et al. 
1982b). This supports a well-documented notion that the mutagenicity observed in normal strains is 
due to endogenous bacterial reduction of the nitro groups (Chiu et al. 1978; Kerklaan et al. 1987; 
Probst et al. 1981; Shimizu et al. 1983; Spanggord et al. 1982b). Human intestinal flora contains 
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may lead to mutagenic effects in humans. Escherichia coli was also examined for gene mutations 
following treatment with 1,3-DNB. Two strains were used: WP2 and WP2 uvrA. The results were 
negative for both, strains (Probst et al. 1981). Another study tested E. coli for DNA damage following 
1,3-DNB treatment. According to the paper, concentrations of 1-10 mg/plate produced bacterial 
toxicity, but it was not clear whether these exposures produced DNA damage or any other form of 
genotoxicity (McGregor et al. 1980). A fungal study tested the effects of 1,3-DNB on mitotic 
recombination in Succharomyces cerevisiae. Doses of up to 32 mg/mL were administered, but no 
genotoxic effects of any kind were observed either with or without metabolic activation (McGregor et 
al. 1980). Refer to Table 2-2 for a further summary of the genotoxic effects of 1,3-DNB exposure. 
A few studies were located that tested the effects of 1,3,5-TNB on mutagenicity, DNA damage, or 
mitotic recombination, As with 1,3-DNB, 1,3,5-TNB was not significantly mutagenic in the 
Sulrnonellu strain deficient in nitroreductase, but gene mutations were observed in strains containing 
the enzyme (Spanggord et al. 1982b). E. coli was used to test the DNA-damaging capabilities of 
1,3,5-TNB. All concentrations produced bacterial toxicity, but it was unclear whether DNA damage 
occurred (McGregor et al. 1980). 1,3,5-TNB did not affect mitotic recombination or produce any 
other observable genotoxic effect in S. cerevisiue (McGregor et al. 1980). Refer to Table 2-3 for a 
further summary of the genotoxic effects of 1,3,5-TNB exposure. 
Unfortunately, the lack of human and animal exposure data makes it difficult to determine whether or 
not 1,3-DNB and 1,3,5-TNB are genotoxic. The available in vitro studies indicate that both chemicals 
have mutagenic potential in S. typhimurium bacteria. S. typhimurium is a classic system used to 
evaluate chemicals for their capacity to induce heritable mutations that potentially can occur in humans 
(Prival 1983). The observed mutagenicity, however, seems to arise from a derivative that is produced 
from nitroreduction. This nitroreduction occurs in rabbits (Parke 1961), rats (McEuen and Miller 
1991; Nystrom and Rickert 1987), hamsters (McEuen and Miller 1991), cultured rat Sertoli cells (Cave 
and Foster 1990; Cossum and Rickert 1987; Lloyd and Foster 1987), and rat hepatocytes (Cossum and 
Rickert 1985). Since it is likely that the same nitroreduction process occurs in humans, then 1,3-DNB and 
1,3,5-TNB may be considered potential human genotoxins. 
Cancer. There is no information regarding carcinogenicity of 1,3,5-TNB or dinitrobenzenes 
including 1,3-DNB. Because of the lack of data regarding the carcinogenicity of 1,3-DNB and 
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2.5 BIOMARKERS OF EXPOSURE AND EFFECT 
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They 
have been classified as markers of exposure, markers of effect, and markers of susceptibility 
(NAS/NRC 1989). 
A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction 
between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a 
compartment of an organism (NAS/NRC 1989). The preferred biomarkers of exposure are generally 
the substance itself or substance-specific metabolites in readily obtainable body fluid(s) or excreta. 
However, several factors can confound the use and interpretation of biomarkers of exposure. The 
body burden of a substance may be the result of exposures from more than one source. The substance 
being measured may be a metabolite of another xenobiotic substance (e.g., high urinary levels of 
phenol can result from exposure to several different aromatic compounds). Depending on the 
properties of the substance (e.g., biologic half-life) and environmental conditions (e.g., duration and 
route of exposure), the substance and all of its metabolites may have left the body by the time biologic 
samples can be taken. It may be difficult to identify individuals exposed to hazardous substances that 
are commonly found in body tissues and fluids (e.g., essential mineral nutrients such as copper, zinc, 
and selenium). Biomarkers of exposure to 1,3-DNB and 1,3,5-TNB are discussed in Section 2.5.1. 
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within 
an organism that, depending on magnitude, can be recognized as an established or potential health 
impairment or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular signals 
of tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital 
epithelial cells), as well as physiologic signs of dysfunction such as increased blood pressure or 
decreased lung capacity. Note that these markers are often not substance specific. They also may not 
be directly adverse, but can indicate potential health impairment (e.g., DNA adducts). Biomarkers of 
effects caused by 1,3-DNB and 1,3,5-TNB are discusskd in Section 2.5.2. 
A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s 
ability to respond to the challenge of exposure to a specific xenobiotic substance. It can be an 
intrinsic genetic or other characteristic or a preexisting disease that results in an increase in absorbed 
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dose, biologically effective dose, or target tissue response. If biomarkers of susceptibility exist, they 
are discussed in Section 2.7, Populations That Are Unusually Susceptible. 
2.5.1 Biomarkers Used to Identify or Quantify Exposure to 1,3-DNB and 1,3,5-TNB 
Very few methods are available for determining the level of 1,3-DNB and its metabolites in human 
blood and urine (for more information see Chapter 6). Because 1,3-DNB is rapidly absorbed, 
metabolized, and excreted, measurement of blood levels of this substance or its metabolites 4s limited 
to exposures of a very large magnitude and that occur within a few, hours of the time at which the 
blood sample is obtained. Results from an in vitro study in rat hepatocytes and microsomes show that 
the relative rate of conversion of 1,3-DNB to nitroaniline is 7 and 12 minutes, respectively (Cossum 
and Rickert 1985). This would make it difficult to accurately determine the level of 1,3-DNB in the 
blood and use it as a marker of exposure. 
Very little information is available about the nature of urinary metabolites of 1,3-DNB in humans. In 
a study that evaluated 1,3-DNB urinary metabolites after a single dermal exposure, amino and nitro 
metabolites were grouped together and reported as a single value relative to the level of 
2,4-dinitrophenol as a standard (Ishihara et al. 1976). Amino and nitro metabolites may be derived 
from a variety of nitroaromatic compounds; thus, they are not specific for 1,3-DNB. 
In rats, 1,3,5-TNB was found to form adducts with blood proteins such as albumin, globulin, and 
globin, and with DNA from tissues, and it was suggested that these adducts may be useful as markers 
for exposure to 1,3,5-TNB (Reddy et .al. 1991). Adducts with albumin and globulin reached a 
maximum one day after a single oral dose, and by day 7 had almost completely disappeared. Adducts 
with globin peaked by day 2, and after 28 days, 20% of the adducts remained. DNA adducts were 
also formed in the spleen, liver and stomach. In the spleen, 100% of the adducts were retained for at 
least 28 days after dosing. 
2.5.2 Biomarkers Used to Characterize Effects Caused by 1,3-DNB and 1,3,5-TNB 
One of the earliest effects of 1,3-DNB exposure is induction of methemoglobin formation. The level 
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There are two questions to be answered in relation to the specificity of methemoglobin formation as a 
biomarker for exposure to 1,3-DNB. One pertains to the nature of the reaction and whether 1,3-DNB 
itself or one of its metabolic intermediaries cause methemoglobin formation. The second question 
relates to the specificity of the reaction, namely the fact that other nitrobenzene compounds and 
dinitrobenzene isomers may also cause methemoglobin formation. Methemoglobin formation is a 
common response to exposure to organic nitrates and is not specific for either 1,3-DNB or 1,3,5-TNB. 
Once these two issues are resolved, it might be possible to select a more specific biomarker for 
1,3-DNB exposure. In the meantime, the levels reflected in a complete blood count can be used as a 
nonspecific biomarker. These are red cell count, hemoglobin concentration, hematocrit, white cell 
count, and a peripheral blood smear for cell morphology. They are rapid, relatively inexpensive, and 
useful for monitoring cohorts of persons possibly exposed to particular members of the nitrobenzene 
class of chemicals. 
Another early symptom of exposure to 1,3-DNB is cyanosis due to oxygen deprivation because of the 
presence of methemoglobin in the blood. These changes are also not specific for 1,3-DNB and may 
be produced by other nitrobenzene compounds and dinitrobenzene isomers. Therefore, cyanosis is not 
a good biomarker for 1,3-DNB exposure. 
Although little information is available regarding neurotoxicity of 1,3-DNB, slight headache, nausea, 
dizziness, and general malaise can accompany exposure to 1,3-DNB (Ishihara et al. 1976; Okubo and 
Shigeta 1982). These symptoms can occur early or be concomitant with cyanosis, but the correlation 
between them was not investigated. These symptoms are not specific to 1,3-DNB exposure and 
therefore are not good biomarkers for 1,3-DNB exposure. 
For more information on biomarkers for renal and hepatic effects of chemicals see ATSDRKDC 
Subcommittee Report on Biological Indicators of Organ Damage (1990) and for information on 
biomarkers for neurological effects see OTA (1990). 
2.6 INTERACTIONS WITH OTHER CHEMICALS 
Limited information is available regarding the influence of other chemicals on the toxicity of 1,3-DNB 
or 1,3,5-TNB. One study reported that a chemical mixture containing 1,3-DNB was not toxic and did 
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or less), and diethylene glycol (15% or more) (Ishihara and Ikeda 1979). As the mixture was made 
more polar either by adding water or short-chain dicarboxylic acids, methemoglobin formation was 
favored. The specific mechanism of this interaction is not known, 
2.7  POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
A susceptible population will exhibit a different or enhanced response to 1,3-DNB/1,3,5-TNB than will 
most persons exposed to the same level of 1,3-DNB and 1,3,5-TNB in the environment. Reasons 
include genetic make-up, developmental. stage, health and nutritional status, and chemical exposure 
history. These parameters result in decreased function of the detoxification and excretory processes 
(mainly hepatic and renal) or the pre-existing compromised function of target organs. For these 
reasons we expect the elderly with declining organ function and the youngest of the population with . 
immature and developing organs will generally be more vulnerable to toxic substances than healthy 
adults. Populations who are at greater risk due to their unusually high exposure are discussed in 
Section 5.6, Populations With Potentially High Exposure. 
No information was located on populations unusually susceptible to toxic effects of 1,3,5-TNB. 
In. the review of the literature regarding toxic effects of 1,3-DNB, no information on any population 
that might be unusually sensitive to 1,3-DNB was found. However, populations that may show 
increased sensitivity include very young children who have an immature hepatic detoxification system 
(and less efficient fetal hemoglobin), individuals with impaired liver or kidney function, and those 
persons who are prone to anemia or are anemic. Also at risk of potential 1,3-DNB toxicity are infants 
with low levels of nicotinamide adenine dinucleotide diaphorase (enzyme that reduces methemoglobin) or 
persons congenitally deficient in this enzyme. At increased risk for induction of 
methemoglobinemia due to exposure to the nitrobenzene class of chemicals may be individuals with 
such genetic traits as glucose 6 phosphate deficiency, sickle cell trait, or genetically induced unstable 
hemoglobin forms. 
2.8 METHODS FOR REDUCING TOXIC EFFECTS 
This section will describe clinical practice and research concerning methods for reducing toxic effects 
of exposure to 1,3-DNB or 1,3,5-TNB. However, because some of the treatments discussed may be 
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experimental and unproven, this section should not be used as a guide for treatment of exposures to 
1,3-DNB or 1,3,5-TNB. When specific exposures have occurred, poison control centers and medical 
toxicologists should be consulted for medical advice. 
No studies were located regarding the reduction of toxic effects of 1,3,5-TNB. In the two 
occupational studies on human dermal exposure to 1,3-DNB, no treatment was described to diminish 
or alleviate 1,3-DNB toxicity (Ishihara and Ikeda 1979; Ishihara et al. 1976). In both studies, affected 
workers were removed from the 1,3-DNB source and recovered without treatment within 40 days 
(Ishihara et al. 1976). 
2.8.1    Reducing Peak Absorption Following Exposure 
In order to reduce absorption of I,3-DNB or 1,3,5-TNB following inhalation exposure, patients should 
be moved to fresh air (HSDB 1994). Following recent ingestion of a substantial amount of either 
chemical, emesis may be indicated unless the patient is obtunded, comatose, or convulsing (HSDB 
1994). Administration of a charcoal slurry, aqueous or mixed with saline cathartic or sorbitol, has also 
been recommended (HSDB 1994). Following dermal exposure, it is recommended that the exposed 
area be washed extremely thoroughly with soap and water (HSDB 1994). Eye contamination should 
be treated by irrigating with copious amounts of tepid water for at least 15 minutes (HSDB 1994). 
2.8.2  Reducing Body Burden 
No studies were located regarding reducing body burden following exposure to 1,3-DNB or 
1,3,5-TNB. 
2.8.3 Interfering with the Mechanism of Action for Toxic Effects 
No agents are known to interfere with 1,3-DNB or 1,3,5-TNB cyanosis (resulting from methemoglobin 
production), but procedures are available and have been recommended to counteract these effects. 
Cyanosis may be treated with high flow (100%) oxygen administration to saturate all remaining normal 
hemoglobin with oxygen (Donovan 1990; Ellenhorn and Barceloux 1988). Elevated levels of 
methemoglobin may be decreased by enhancing the rate of conversion of methemoglobin to 
hemoglobin. Methylene blue is the antidote of choice in this situation. Ascorbate has been suggested 
 
 
61 1,3-DNB AND 1,3,5-TNB 
2. HEALTH EFFECTS 
as an alternative reducing agent, but it is believed to have limited efficacy (Donovan 1990; Ellenhorn 
and Barceloux 1988). Methylene blue is administered intravenously. It is first reduced to 
leukomethylene blue by NADPH-dependent methemoglobin reductase in the red blood cell. The 
leukomethylene blue then acts as an electron donor to reduce methemoglobin to hemoglobin 
nonenzymatically. Use of methylene blue is generally indicated when methemoglobin levels exceed 
30% but may be used at lower methemoglobin levels in persons with pulmonary or cardiovascular 
disease or with preexisting anemia (Donovan 1990; Ellenhom and Barceloux 1988; Goldfrank et al. 
1990). Methylene blue is ineffective in persons with glucose-6-phosphate dehydrogenase deficiency 
and of limited effectiveness in persons with NADPH-dependent methemoglobin reductase deficiencies 
(Donovan 1990; Ellenhom and Barceloux 1988; Goldfrank et al. 1990). Severe hemolytic anemia may 
develop if methylene blue is given to persons with glucose-6-phosphate dehydrogenase deficiency. 
Caution should also be used when administering methylene blue to others because high doses 
(>7 mg/kg) may increase methemoglobin levels and cause hemolysis (Donovan 1990; Ellenhom and 
Barceloux 1988). In cases of failure of methylene blue therapy, exchange transfusions have been used 
to replace hemoglobin and remove the absorbed toxin (Donovan 1990; Ellenhom and Barceloux 1988). 
If seizures develop following exposure to 1,3-DNB or 1,3,5-TNB, administration of diazepam IV bolus 
has been suggested. Administration of phenytoin is recommended if seizures are uncontrollable or 
recur (HSDB 1994). 
2.9 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of 1,3-DNB and 1,3,5-TNB is available. Where adequate 
information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is 
required to assure the initiation of a program of research designed to determine the health effects (and 
techniques for developing methods to determine such health effects) of 1,3-DNB and 1,3,5-TNB. 
The following categories of possible data needs have been identified by a joint team of scientists from 
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met, 
would reduce or eliminate the uncertainties of human health assessment. This definition should not be 
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identified data needs will be evaluated and prioritized, and a substance-specific research agenda will be 
proposed. 
2.9.1   Existing Information on Health Effects of 1,3-DNB and 1,3,5-TNB 
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to 
1,3-DNB and 1,3,5-TNB are summarized in Figure 2-3 and 2-4, respectively. The purpose of these 
figures is to illustrate the existing information concerning the health effects of 1,3-DNB and 
1,3,5-TNB. Each dot in the figure indicates that one or more studies provide information associated 
with that particular effect. The dot does not necessarily imply anything about the quality of the study 
or studies, nor should missing information in this figure be interpreted as a “data need.” A data need, 
as defined in ATSDR’s Decision Guide for Identifying Substance-Specific Data Needs Related to 
Toxicological Profiles (ATSDR 1989e), is substance-specific information necessary to conduct 
comprehensive public health assessments. Generally, ATSDR defines a data gap more broadly as any 
substance-specific information missing from the scientific literature. In addition to this information, a 
database is available through the National Institutes of Health on the metabolism and toxicity of 
1,3-DNB. 
No studies were located concerning the health effects of 1,3,5-TNB in humans. Information on effects 
in animals was limited to acute oral and dermal data. 
With regard to human health effects of 1,3-DNB, the few available studies involved acute-duration 
occupational exposure to 1,3-DNB by the inhalation and dermal routes, a case of accidental ingestion 
of a nitrobenzene dye, and a case of an experimenter who self-applied 1,3-DNB dermally for research 
purposes. No information was located on intermediate- or chronic-duration exposures in humans by 
any route. No information is available regarding immunologic, developmental, reproductive, 
genotoxic, or cancer effects in humans by any route of exposure. 
Virtually all of the data regarding the health effects of 1,3-DNB in animals were obtained from studies 
in which 1,3-DNB was administered orally. No information is available concerning health effects in 
animals following inhalation exposure, and only two reports on dermal exposure to 1,3-DNB were 
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potential exposure via those two routes for humans living near ammunition plants and workers in the 
dyestuffs, plastics, rubber, and other industries. 
2.9.2 Identification of Data Needs 
Acute-Duration Exposure. Populations living in the vicinity of ammunition plants may be 
exposed to 1,3-DNB or 1,3,5-TNB for a short time. Exposure would probably occur via the oral 
route, but inhalation and dermal exposures cannot be excluded. 
No information regarding health effects of 1,3,5-TNB administered by any route is available in 
humans. Data presented in abstract form provided limited information on oral and dermal toxicity in 
animals (Desai et al. 1991). Therefore, studies addressing toxic effects of 1,3,5-TNB in animals after 
acute oral exposure (since this is the most likely route of exposure for human populations in the 
vicinity of ammunition plants) would provide needed information for estimation of possible 1,3,5-TNB 
toxicity in humans. Also needed are acute exposure studies of 1,3,5-TNB after inhalation and dermal 
exposures because exposure by these routes may occur in spite of the low volatility of these 
compounds. 
The hematological system is the major target of 1,3-DNB toxicity in humans and animals following 
acute exposure by any route. Biochemical changes that occur in blood are responsible for 
methemoglobin formation leading to oxygen deprivation in the tissues (Donovan 1990; Ellenhorn and 
Barceloux 1988). That change further results in cyanosis (Linder et al. 1988, 1990; Philbert et al. 
1987b; Reader et al. 1991). Studies in animals further indicate that adverse neurological effects such 
as ataxia (Cody et al. 1981; Linder et al. 1988, 1990; Philbert et al. 1987b), and reproductive effects, 
such as altered spermatogenesis and infertility (Cody et al. 1981; Hess et al. 1988; Linder et al. 1988, 
1990; Moore et al. 1992; Reader et al. 1991) occur after acute oral exposure to 1,3-DNB. These 
potential targets have not been studied in humans. An acute oral MRL was derived for 1,3-DNB 
based on adverse reproductive effects in male rats (Linder et al. 1990) (see Section 2.4). 
Respiratory changes have not been studied in either humans or animals after acute inhalation exposure 
to 1,3-DNB. However, slight dyspnea was observed in humans following an acute inhalation exposure 
to 1,3-DNB (Okubo and Shigeta 1982). Although the volatility of 1,3-DNB is low and thus the levels 
in the atmosphere are expected to be low, lung absorption of 1,3-DNB is possible in areas close to 
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ammunition plants and in occupationally exposed workers. It would therefore be useful to perform 
studies that examine the respiratory effects after acute inhalation exposure to 1,3-DNB. Limited data 
indicate that humans can absorb 1,3-DNB through the skin (Ishihara et al. 1976; White and Hay 1901), 
and although.there was no evidence of adverse respiratory effects, well-conducted studies in animals 
may provide valuable supportive information. 
Intermediate-Duration Exposure. No studies were located on intermediate-duration exposure to 
1,3,5-TNB in humans or animals by any route. Therefore, studies in animals would provide useful 
information. There were also no studies on intermediate-duration exposure by any route to 1,3-DNB 
in humans. Studies in laboratory animals following intermediate-duration oral exposure to 1,3-DNB 
showed that a major target is the hematological system (see Section 2.2.2.2), but other targets include 
the central nervous system (Cody et al. 1981; Linder et al. 1986) (see Section 2.2.2.4) and the male 
reproductive system (Cody et al. 1981; Linder et al. 1986) (see Section 2.2.2.5). An intermediate oral 
MRL was derived for 1,3-DNB based on hematological effects in rats exposed for 12 weeks (Linder et 
al. 1986) (see Section 2.4). Studies to determine whether adverse effects occur in animals after 
inhalation or dermal intermediate duration exposure would be useful. 
Chronic-Duration Exposure and Cancer. No studies were located following chronic-duration 
exposure to either 1,3-DNB or 1,3,5-TNB in humans or animals. This may be because both 
compounds were shown to be potent acute toxicants. Animal studies that examine the effects of 
1,3-DNB and 1,3,5-TNB after low-level chronic exposure by oral, dermal, and inhalation routes would 
be of value to determine whether exposures via these routes could cause toxicity in populations living 
in the vicinity of ammunition plants or in those exposed in industries where these chemical are used. 
Because of the lack of data on the carcinogenicity of 1,3-DNB and 1,3,5-TNB, and in the absence of 
data to adequately describe the mechanism of action, these two compounds are not presently classified 
as carcinogens. Studies to determine if these two compounds have carcinogenic potential via 
inhalation, oral and dermal exposure routes would be useful. 
Genotoxicity. No human or animal in viva studies on the genotoxicity of I,3-DNB or 1,3,5-TNB 
were located. However, several bacterial mutagenicity studies were located for both chemicals. 
Depending on the strain of S. typhimurium used in mutagenicity, testing both compounds caused 
nonsignificant frameshift mutations and base-pair substitutions (Chiu et al. 1978; Furukawa et al. 1985; 
67 1,3-DNB AND 1,3,5-TNB 
2. HEALTH EFFECTS 
Gamer and Nutman 1977; Kaden et al. 1979; Melnikow et al. 1981; Spanggord et al. 1982b)
 
indicating that both 1,3-DNB and 1,3,5-TNB have a mutagenic potential. The results of several
 
studies have also suggested a link between the mutagenicity of 1,3-DNB/1,3,5-TNB and nitroreduction
 
(Chiu et a1.1978; Kerklaan et al. 1987; Probst et al. 1981; Shimizu et al. 1983; Spanggord et al. 1982b).
 
S: typhimurium strains deficient in enzyme nitroreductase had nonsignificant gene mutations after 
exposure to either 1,3-DNB or 1,3,5-TNB (Spanggord et al. 1982b). Further investigation into this link 
using mammalian cells/systems would be helpful in establishing if the same processes also occur in 
mammalian cells. 
Reproductive Toxicity. No studies were found describing reproductive effects of 1,3-DNB in 
humans and 1,3,5-TNB in humans and animals. Studies in laboratory animals exposed orally to 
1,3-DNB show that 1,3-DNB is a potent testicular toxicant (see Section 2.2.2.5) (Blackburn et al. 
1988; Cody et al. 1981; Evenson et al. 1989b; Hess et al. 1988; Linder et al. 1986, 1988; Reader et al. 
1991). An acute-duration oral MRL was derived on the study by Linder et al. (1990) (see Section 
2.4). No studies in animals were found regarding the reproductive effects of exposure to 1,3-DNB by 
inhalation or dermal routes. Therefore, studies examining the effects on reproduction (including 
exposure of females during gestation) following inhalation, oral, and dermal exposure to 1,3-DNB 
would be useful, since oral exposure is the most likely route for people living near ammunition plants, 
but inhalation and dermal exposure may be more relevant in industrial settings. Animal studies 
following exposure to 1,3,5-TNB by any of the three routes would be useful to establish if there is 
potential for reproductive toxicity in people living close to ammunition plants or in occupationally 
exposed workers. 
Developmental Toxicity. No human or animal studies on the developmental effects of 1,3-DNB 
or 1,3,5-TNB for any exposure route were located in this literature review. Animal studies examining 
postnatal survival and developmental effects following maternal exposure by all routes of exposure 
would be helpful since potential oral exposure exists for populations living near ammunition plants, 
and inhalation and dermal exposure may occur in industries involved in dyestuff, plastics, and rubber 
production. 
Immunotoxicity. No information on immunotoxicity after exposure to 1,3,5-TNB by any of the 
three routes is available in humans or animals. Therefore, animal studies following acute, 
intermediate, and chronic exposure to 1,3,5-TNB via all three routes would help in estimating the 
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potential immunotoxic effects in humans. Spleen enlargement was reported in acute- (Blackburn et al. 
1988) and intermediate-duration (Cody et al. 1981; Linder et al. 1986) studies in animals. These 
effects, however, were secondary to adverse hematological effects. Studies in laboratory animals 
following acute exposure to 1,3-DNB by the oral route would help define possible effects on antibody 
production and cellular immunity. This information could be used to determine populations sensitive 
to possible exposure to 1,3-DNB at locations close to ammunition plants or in specific workplaces. 
Neurotoxicity. The few human studies available on dermal and inhalation exposure to 1,3-DNB 
indicate that the central nervous system. may be a target of 1,3-DNB toxicity (Ishihara et al. 1976; 
Okubo and Shigeta 1982) (see Sections 2.2.1.4 and 2.2.3.4). Studies in animals support this finding 
although results in animal studies were mostly obtained after acute oral exposure to 1,3-DNB (Linder 
et al. 1988, 1990; Philbert et al. 1987b). The animal data have also shown that the severity of 
neurotoxic effects is dose dependent and that neurotoxicity is probably due to decreased oxygenation 
because of increased levels of methemoglobin (Cody et al. 1981; Linder et al. 1988; Philbert et al. 
1987b). Laboratory animal studies that focus on subtle neurological effects following acute, 
intermediate, or chronic exposure to a range of doses via oral, inhalation, and dermal routes would 
help to better estimate potential neurotoxic effects in humans living near ammunition plants and in 
workers who might be exposed in certain occupational settings. 
No studies were found describing neurotoxicity of 1,3,5-TNB in humans or animals. Therefore, 
studies following oral, inhalation, or dermal exposure to 1,3,5-TNB would be very helpful in 
evaluating potential neurotoxic effects close to ammunition plants. 
Epidemiological and Human Dosimetry Studies. No epidemiological studies on exposure to 
either 1,3-DNB or 1,3,5-TNB have been located. Studies of worker populations and populations living 
near ammunition plants might be useful to determine effects of low-level acute, intermediate, or 
possibly chronic exposure to 1,3-DNB or 1,3,5-TNB. If such populations are identified, carefully 
designed information gathering of immunologic, reproductive, hematologic, neurotoxic, genotoxic, 
developmental, and carcinogenic effects of the two compounds should be implemented. The 
correlation of these effects with the levels of methemoglobin associated with exposure would provide 
useful information regarding potential exposure of populations living near ammunition plants and 
occupationally exposed workers. 
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Biomarkers of Exposure and Effect. 
Exposure. Exposure to 1,3-DNB is currently measured indirectly by determining levels of 
methemoglobin in the blood (Donovan 1990). However, increased methemoglobin formation is not a 
specific response to 1,3-DNB exposure and may occur after exposure to other nitrobenzene compounds 
such as the other two isomers of dinitrobenzene. Determination of methemoglobin levels is widely used 
and is a reliable detection method. Very few methods are available for direct evaluation of 1,3-DNB 
levels, and they are not extensively used, probably because of the relatively rapid rate of 
conversion of 1,3-DNB to its degradation products (Cossum and Rickert 1985). Preliminary data 
suggested that the formation of adducts of 1,3,5-TNB with tissue DNA and/or with blood proteins may 
be useful as markers for exposure to 1,3,5-TNB (Reddy et al. 1991). Further research with both 
1,3-DNB and 1,3,5-TNB in the area of adduct formation could provide valuable additional 
information. 
Effect. Cyanosis is also an early symptom of exposure to 1,3-DNB (Okubo and Shigeta 1982) and is 
a result of oxygen deprivation due to the presence of methemoglobin in the blood. However, it is not 
specific and may occur after exposure to other nitrobenzene compounds or other non-related 
chemicals. 
Nitroaniline is one of the 1,3-DNB metabolites and animal studies designed to evaluate its level in the 
urine would give information about the usefulness of nitroaniline as a biomarker of 1,3-DNB exposure. 
No studies in humans or animals were located dealing with biomarkers of effects after exposure to 
1,3,5-TNB. Therefore, research efforts aimed to identifying such a biomarker would be useful. 
Absorption, Distribution, Metabolism, and Excretion. The few studies available in humans 
indicate that 1,3-DNB can be readily and rapidly absorbed via the dermal and inhalation routes 
(Ishihara et al. 1976; Okubo and Shigeta 1982). Quantitative information on the rates of absorption of 
1,3-DNB in humans and animals following all routes of exposure are limited (see Section 2.3.1). 
Obtaining additional quantitative data in animals via all exposure routes and using different vehicles 
would be helpful for estimating absorption in humans. 
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No studies were located regarding distribution following inhalation exposure to 1,3-DNB and 
1,3,5-TNB in humans and animals. Data on distribution via the dermal and oral routes for humans 
were not located. There is limited information describing distribution following acute oral exposure to 
1,3-DNB in animals. Studies indicate that 1,3-DNB is distributed in the blood, liver, kidneys, and fat 
tissue (Philbert et al. 1987b; Parke 1961). Additional studies regarding acute oral and dermal 
exposures would help elucidate the distribution pattern of 1,3-DNB. The oral route is the most likely 
route of exposure near ammunition plants, while workers in the plants would most likely be exposed 
by inhalation of dusts and through dermal contact. Only one study was located that provided 
information regarding distribution of 1,3,5-TNB in animals after acute oral exposure (Reddy et al. 
1991). Further studies via all three routes of exposure would be valuable to determine the distribution 
pattern for 1,3,5-TNB. 
No information was located regarding metabolism of 1,3-DNB in humans and animals following 
inhalation exposure. Information on metabolism following oral exposure is available (see Section 
2.3.3.2); however, more information would be useful because the potential exists for exposure to occur 
in humans via this route. 
No studies were located on absorption or metabolism following oral inhalation or dermal exposure to 
1,3,5-TNB in humans or animals. Therefore, animal studies are needed to elucidate the absorption 
process and metabolic path following exposure to 1,3,5-TNB. 
No information was located regarding excretion in humans or animals following inhalation or dermal 
exposure to 1,3-DNB or following exposure to 1,3,5-TNB by any route. Studies in these areas would 
provide useful information since exposure to these compounds can occur by all three routes. Several 
studies in animals describe excretion following oral exposure to 1,3-DNB (see Section 2.3.4.2). These 
studies show quantitatively that the metabolites (2,4-diaminophenol, 1,3-phenylenediamine, 
1,3-nitroaniline, and 2-amino-4-nitrophenol) (Parke 1961) are excreted primarily in the urine. 
Differences in excretion of metabolites have been observed in several species following oral exposure. 
It is not clear which species is best for determining excretion patterns in humans. Therefore, studies to 
determine which is the best animal model to be used for extrapolation of data on distribution and 
excretion patterns of 1,3-DNB to humans would be useful. 
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Comparative Toxicokinetics. Several studies using different animal species (rat, hamster, rabbit) 
indicate that the kinetics of 1,3-DNB differ across species (McEuen and Miller 1991; Parke 1961; 
Watanabe et al. 1976). The differences are primarily quantitative. On the basis of kinetic data alone, 
it is not possible to identify common target organs, but distribution data and toxicity data after oral 
exposure together suggest similar target/systems organs (hematological and reproductive systems, liver 
and kidneys. Interspecies differences between rats and hamsters include metabolism and excretion 
(McEuen and Miller 1991). The interspecies differences, and the lack of data across different routes, point 
to the possible problem in comparing the toxicokinetics of 1,3-DNB in animals with that in humans. 
Additional studies using several species exposed to 1,3-DNB by the oral route would help in determining 
differences and similarities between humans and animals. Also needed are animal studies on 1,3-DNB 
toxicokinetics after inhalation and dermal exposures. Since no information was located on toxicokinetics 
of 1,3,5-TNB after inhalation, oral, or dermal exposures, animal studies addressing these issues would be 
useful in addressing the data needs. 
Methods for Reducing Toxic Effects. The most notable clinical sign of exposure to 1,3-DNB 
(and nitroaromatic compounds in general) is increased formation of methemoglobin that can lead to 
cyanosis (see Section 2.4). This may occur in humans after inhalation (Okubo and Shigeta 1982), oral 
(Kumar et al. 1990) or dermal (Ishihara et al. 1976) exposure. Methylene blue is considered the 
antidote of choice for methemoglobinemia (Donovan 1990; Ellenhorn and Barceloux 1988) and was 
successfully applied in a case of oral poisoning (Kumar et al. 1990). However, methylene blue is 
ineffective in populations with certain enzymes deficiencies, or may cause unwanted side effects; 
therefore, studies aimed at developing alternative antidotes for the treatment of methemoglobinemia 
would be useful. 
2.9.3 Ongoing Studies 
Ongoing studies regarding the health effects of 1,3-DNB and 1,3,5-TNB were reported in the Federal 
Research in Progress File (FEDRIP 1994) database. Table 2-4 summarizes the ongoing studies that 
address the health effects of 1,3-DNB and 1,3,5-TNB.’ The table also includes research communicated 
in recent abstracts. 
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 3.1 CHEMICAL IDENTITY 
Information regarding the chemical identity of 1,3-DNB and 1,3,5-TNB is located in Table 3-l. 
3.2     PHYSICAL AND CHEMICAL PROPERTIES 
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4.1      PRODUCTION 
1,3-DNB and 1,3,5-TNB have both been prepared by the nitration of benzene with a mixture of nitric 
acid and sulfuric acid (HSDB 1994). However, I,3-DNB is produced in a two-step nitration process 
under vigorous conditions, whereas 1,3,5-TNB has been produced from a single-step nitration process 
with a mixture of fuming nitric acid and fuming sulfuric acid (HSDB 1994; Mark et al. 1978). 
1,3-DNB has been synthesized in small quantities as a by-product in the nitration of toluene to form 
TNT (Mitchell and Dennis 1982). 
1,3,5-TNB has also been produced from TNT by removing a methyl group (Sax and Lewis 1987). 
Trinitrobenzoic acid, the result of oxidation of TNT, has also been decarboxylated to yield 1,3,5-TNB 
(Merck 1989). 
Production volume figures for 1,3-DNB are not easily available because it is produced as a mixture 
with other nitrobenzene isomers during the manufacturing process. In the United States, DuPont alone 
reportedly generated 70,000-72,000 pounds of 1,3-DNB annually from production of dinitrobenzene 
and nitrobenzene (EPA 1991b). The production volumes for 1,3-DNB by other manufacturers are not 
known. Production data for 1,3,5-TNB by producers in the United States are unknown. 
Table 4-1 reports the other facilities, besides DuPont, in the United States that produce and/or process 
1,3-dinitrobenzene. The data reported in Table 4-1 are derived from the Toxics Release Inventory 
(TRI) of EPA (TR192 1994). Only certain types of facilities were required to report to the TRI 
databank of EPA. Hence, this is not an exhaustive list. The Aldrich Chemical Company (Milwaukee, 
Wisconsin) and Janssen Chimica (Gardena, California) also produced 1,3-DNB for commercial sale 
and use (Van et al. 1991). 1,3,5-TNB has been manufactured commercially by Kodak Park Division 
(Rochester, New York) (OHM/TADS 1991). 
Since 1,3,5-TNB releases are not required to be reported under SARA Section 313, there are no data 
for these compounds in the 1992 Toxics Release Inventory (TR192 1994). 
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4.2 IMPORT/EXPORT 
In 1971, an estimated 10,100 pounds of 1,3-DNB were imported into the United States (EPA 1976). 
However, current import and export data for 1,3-DNB are not available (HSDB 1994). Data for 
import and export volumes of 1,3,5-TNB are also not available. 
4.3 USE 
Both 1,3-DNB and 1,3,5-TNB have been used for their explosive properties (HSDB 1994). 1,3-DNB 
has been suggested as a possible substitute for the explosive TNT (HSDB 1994). 1,3-DNB has been 
used as a camphor substitute in nitrocellulose, a compound used in explosives and propellants (HSDB 
1994; Sax and Lewis 1987). 1,3-DNB was manufactured during both world wars as a component in 
the explosive roburite (EPA 1976). 1,3,5-TNB has been classified as a high explosive and has been 
used in military and commercial explosive compositions (Merck 1989; Sax and Lewis 1987). A more 
powerful explosive than TNT, 1,3,5-TNB is less sensitive than TNT to impact (Merck 1989). 
1,3,5-TNB has also been used as an explosive for oil wells and mining operations (OHM/TADS 1991). 
Commercially, 1,3-DNB has been used extensively as an organic intermediate for m-phenylenediamine, a 
chemical used in the synthesis of aramid fibers and spandex (HSDB 1994). 1,3-DNB is an industrial 
chemical used in organic synthesis and dyes (McFarlane et al. 1987a). In the medical field, 1,3-DNB has 
been used as an indicator in the detection of 17-ketosteroids. 1,3-DNB has acted as an electrolytic reducer 
in the preparation of aminocresols (HSDB 1994). Other uses for 1,3,5-TNB include use as a vulcanizing 
agent in the processing of natural rubber and as an indicator in acid-base reactions in the pH range of 
12.0-14.0 (HSDB 1994). 
4.4 DISPOSAL 
1,3,5-TNB is classified as an EPA hazardous waste and disposal must be carried out according to EPA 
regulations (HSDB 1994). Wastes generated in the manufacture of explosive components such as 
1,3-DNB and 1,3,5-TNB are also characterized as hazardous wastes and EPA regulations for disposal 
must be followed (EPA 1990a). For more information on the regulations that apply to 1,3-DNB and 
1,3,5-TNB, see Chapter 7. 
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Disposal of both 1,3-DNB and 1,3,5-TNB can be accomplished by high-temperature incineration in a 
device equipped with an afterburner and a scrubber (HSDB 1994). 1,3-DNB and 1,3,5-77VB have 
been incinerated by dissolution in a combustible solvent or inert material; the resulting mixture is then 
sprayed into an incinerator (HSDB 1994; OHM/TADS 1991). 1,3-DNB has also been incinerated after 
first being wrapped in paper to allow for burning of 1,3-DNB in an unconfined condition (HSDB 
1994). 1,3,5-TNB has been classified as a potential candidate for both fluidized bed incineration at 
temperatures between 450 and 980 °C and rotary kiln incineration at temperatures between 820 and 
1,600 °C (EPA 1981). Product residues and sorbent media remaining after high-temperature 
incineration and scrubbing of 1,35TNB have been packaged in 17H epoxy-lined drums and 
transported to a RCRA-approved landfill for disposal (OHM/TADS 1991). If appropriate incineration 
facilities are not available for the disposal of 1,3-DNB, the compound may be buried in a chemical 
waste landfill, although this practice is not acceptable at municipal sewage treatment plants 
(OHM/TADS 1991). 
Recently investigated methods of treating waste waters contaminated with 1,3-DNB or 1,3,5-TNB and 
related products include biological treatment, stripping, solvent extraction, and activated carbon 
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5.1 OVERVIEW 
The nitroaromatic compounds 1,3-DNB and 1,3,5-TNB are used in the manufacture of explosives. 
They are formed as by-products during the manufacture of TNT. 1,3-DNB is also used in the 
manufacture of industrial solvents and dyes. Effluents from Army ammunition plants are primarily 
responsible for the releases of both compounds into the environment. When released to the air, both 
compounds have the potential to undergo photolysis. 1,3,5-TNB will also slowly react with 
photochemically generated hydroxyl radicals, but this is not a significant fate process, No data were 
located for 1,3-DNB regarding reaction with hydroxyl radicals. Both compounds are mobile in soil 
and can leach into the groundwater. Hydrolysis is not expected to be an important fate process since 
aromatic nitro compounds are generally resistant to chemical hydrolysis under environmental 
conditions. Both compounds are expected to undergo photolysis in water; however, no photolysis data 
were located for 1,3,5-TNB. The photolytic half-life of 1,3-DNB in water was 23 days. 1,3-DNB can 
undergo biodegradation under aerobic and anaerobic conditions in water and soil. 1,3,5-TNB is 
subject to biodegradation under aerobic conditions in water; however, no data were located regarding 
anaerobic biodegradation in water or anaerobic and aerobic biodegradation in soil. 1,3-DNB and 
1,3,5-TNB have been detected in groundwater and soil in the vicinity of Army ammunition plants at 
levels ranging from ppb to ppm. 
The general population is not likely to be exposed to either 1,3-DNB or 1,3,5-TNB. Exposure to both 
compounds is expected to be limited to areas around Army ammunition plants and other industries, 
such as dyestuff, and plastic and rubber manufacturing, where these compounds are used. The most 
likely route of exposure to these compounds is ingestion of contaminated drinking water. 
Both 1,3-DNB and 1,3,5-TNB have been identified in 12 and 14 sites, respectively, of the 1,397 
hazardous waste sites on the NPL (HazDat 1994). The frequency of these sites within the United 
States can be seen in Figure 5-1. It should be noted that the number of sites actually tested for 




83 1,3-DNB AND 1,3,5-TNB 
5. POTENTIAL FOR HUMAN EXPOSURE 
5.2 RELEASES TO THE ENVIROMENT 
5.2.1 Air 
Because 1,3-DNB and 1,3,5-TNB are used in the manufacture of explosives, industrial solvents, 
plastics, rubber, and dyes, they may be released to air as a result of such uses (Hallas and Alexander 
1983). It has been reported by DuPont that approximately 60 pounds of 1,3-DNB are released into the 
atmosphere annually during processing of the compound (EPA 1991b). According to TR192 (1994) 
data given in Table 5-1, an estimated total of 1,251 pounds of 1,3-DNB, amounting to 100% of the 
total environmental release, was discharged to the air from the two manufacturing and processing 
facilities in the United States in 1992. The TRI data should be used with caution since only certain 
types of facilities are required to report. This is not an exhaustive list. 
Since 1,3-DNB has a very low vapor pressure, insignificant amounts would volatilize from water 
(HSDB 1994; Lyman et al. 1982). Therefore, the amount of 1,3-DNB that might enter the air through 
evaporation from aquatic effluent streams would be minuscule. 
5.2.2 Water 
Both 1,3-DNB and 1,3,5-TNB are formed as by-products during the manufacture of TNT and can be 
released to water in discharges from TNT production facilities and munitions plants (ATSDR 1989a, 
1989b; Mitchell and Dennis 1982; Spanggord et al. 1982a). 1,3,5-TNB is also formed as a by-product 
in TNT photolysis (Army 1987b). 1,3-DNB has been detected in the commercial product TNT ‘and 
can therefore be present in effluents from munitions blending and loading operations (Mitchell and 
Dennis 1982). 1,3-DNB can also be produced in water by the photoconversion of the munitions 
by-product 2,4-dinitrotoluene (Higson 1992). 1,3-DNB is one of many nitroaromatic compounds used 
in the manufacture of dyes and industrial solvents and may be released to water as a result of such 
uses (Hallas and Alexander 1983). 1,3-DNB can be released to water through wastes and waste 
discharges from the dye manufacturing process (Dey and Godbole 1986). 
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5.2.3 Soil 
Both 1,3-DNB and 1,3,5-TNB may be released to soil in waste discharges from the manufacture of 
TNT, or from the disposal of TNT wastes, or wastes from munitions plants (Army 1981, 1984b; 
ATSDR 1987, 1989c; Spalding and Fulton 1988). 1,3-DNB can be released to soil through wastes and 
waste discharges from the dye manufacturing process (Dey and Godbole 1986). 
1,3-DNB and 1,3,5-TNB were not listed in the CLPSD of chemicals detected in soil samples taken at 
NPL sites only (CLPSD 1989). 
5.3   ENVIRONMENTAL FATE 
5.3.1 Transport and Partitioning 
The estimated vapor pressure of 1,3-DNB is <l.0 mm Hg at 20 °C (HSDB 1994), indicating that 
1,3-DNB will exist entirely in the vapor phase in the atmosphere (Eisenreich et al. 1981). Based on a 
vapor pressure of 3.2X10-6 mm Hg at 25°C (see Table 3-2) 1,3,5-TNB is expected to exist partly in 
the vapor phase and partly in the particulate phase (Eisenreich et al. 1981). The transport of vapor 
phase 1,3-DNB from the atmosphere to the terrestrial surface is likely to occur mainly by wet 
deposition, while 1,3,5-TNB is likely to be transported by both wet and dry deposition (Bidelman 
1988). 
The partitioning of 1,3-DNB in water between water and the suspended solid and sediment has been 
estimated. Simulation studies based on the octanol-water partition coefficient predict that >99% of 
1,3-DNB will remain in the water column and <1% will be adsorbed to suspended solid and sediment 
(EPA 1991b). 1,3,5-TNB with an octanol-water partition coefficient value lower than 1,3-DNB (see 
Table 3-2), is expected to exist almost exclusively in the water column. 
Henry’s law constant for 1,3-DNB was estimated to be 2.33x10-6 atm-m3/mol (HSDB 1994). Based 
on this value, volatilization from deep quiescent water bodies is expected to be a slow fate process for 
1,3-DNB (Lyman et al. 1982). Henry’s law constant for 1,3,5-TNB was estimated to be 3.08x10-9 
atm-m3/mol at 25 °C using a group structural estimation method (Hine and Mookerjee 1975; HSDB 
1994). Based on this value, 1,3,5-TNB is essentially nonvolatile (Lyman et al. 1982). This means 
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that it is very unlikely that large amounts of either 1,3-DNB or 1,3,5-TNB would be released into the 
air from contaminated waters. 
The soil organic carbon adsorption coefficient (Koc) values for 1,3-DNB and 1,3,5-TNB were 
calculated to be 213.8 and 75.86, respectively (Army 1987b). Based on these Koc values, 1,3-DNB 
and 1,3,5-TNB are expected to exhibit moderate and high mobility, respectively, in soil; thus, both 
compounds can leach into groundwater (Swann et al. 1983). However, nitroaromatic compounds show 
stronger binding toward clay minerals in soil as a result of complex formation between electron donor 
groups present at mineral surfaces and electron accepting properties of nitroaromatics (Haderlein and 
Schwarzenbach 1993). This effect is expected to significantly decrease the mobility of such 
compounds in soil (Haderlein and Schwarzenbach 1993). 
The logarithm of the n-octanollwater partition coefficient (log Kow) is a useful preliminary indicator of 
the bioconcentration potential of a compound. The calculated log Kow values for 1,3-DNB and 
1,3,5-TNB are 1.52 and 1.18 (Deneer et al. 1987), respectively, suggesting a low potential for 
.bioaccumulation. An experimental bioconcentration factor (BCF) of 1,3-DNB for the guppy, Poecilia 
reticulata, was reported to be 74.13 (Deneer et al. 1987). This BCF indicates that bioaccumulation in 
aquatic organisms is not an important fate process. BCF data were not located for 1,3,5-TNB. 
The uptake, distribution, and metabolism of 1,3-DNB were studied in hydroponically grown mature 
soybean plants (McFarlane et al. 1987a). Initial uptake rate constants of 1,3-DNB by soybean plants 
determined by measuring either chemical loss from solution, 14C concentration in plants, or root 
uptake were similar, ranging from 17 to 22.2 mL/minute. 1,3-DNB remained mostly in the roots, and 
14C was slowly translocated to the shoots. Examination of 14C in the leaves indicated that the 
translocated chemicals were probably degradation products rather than 1,3-DNB and were metabolized in 
the roots. The degradation products, however, were not identified (McFarlane et al. 1987a). 
No studies were located regarding plant uptake of 1,3,5-TNB. 
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5.3.2 Transformation and Degradation 
5.3.2.1 Air 
Based on an estimated reaction rate constant of 1.3x10-15 cm3/mol-second at 25 °C and an average 
hydroxyl radical concentration of 5.0x105molecule/cm3, the half-life for the reaction of 1,3,5-TNB 
vapor with photochemically generated hydroxyl radicals in the atmosphere has been estimated to be 
34 years (Atkinson 1985, 1987; HSDB 1994). No data were located regarding the photooxidation of 
1,3-DNB. Although no data were located regarding direct photolysis of 1,3-DNB or 1,3,5-TNB, both 
compounds have the potential to photolyze when exposed to sunlight because both can absorb light at 
wavelengths greater than 290 nm (EPA 1976; Mill and Mabey 1985). 
5.3.2.2 Water 
No data were located regarding the hydrolysis of 1,3-DNB and 1,3,5-TNB. However, neither 
compound is expected to undergo hydrolysis since aromatic nitro compounds are generally resistant to 
chemical hydrolysis under environmental conditions (Lyman et al. 1982). The transformation of 
1,3-DNB in water due to reactions with oxidants present in natural bodies of water is not expected to 
be important in environmental fate processes (EPA 1991b). 
If released to water, 1,3-DNB and 1,3,5-TNB may be subject to direct photolysis when exposed to 
sunlight because both compounds can absorb light at wavelengths greater than 290 nm (EPA 1976; 
Mill and Mabey 1985). However, no data were located regarding the photolysis of 1,3,5-TNB in 
water. The photolytic half-life of 1,3-DNB in pure water was calculated to be 23 days (Simmons and 
Zepp 1986). A three- to four-fold increase in the rate of photoreaction of 1,3-DNB was observed in 
ambient waters containing natural humic substances or in distilled water containing dissolved humic 
materials compared to reaction without humic substances (Simmons and Zepp 1986). This 
enhancement of the reaction rate has been attributed to catalysis of the photoreaction by 
photosensitization effects of humic substances. 
The biodegradation of 1,3-DNB in water requires the presence of microorganisms that are acclimated 
to 1,3-DNB (EPA 1991b). Therefore, biodegradation of 1,3-DNB is not likely to occur in pristine 
waters. A mixed bacterial culture, with Pseudomonas predominating, adapted to metabolize phenol as 
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the sole source of carbon had the ability to degrade 100 mg/L 1,3-DNB and 1,3,5-TNB under aerobic 
conditions (Chambers et al. 1963). Both compounds were slowly oxidized, and 1,3-DNB was 
degraded at a slower rate than 1,3,5-TNB. Cultures to which 1,3-DNB and 1,3,5-TNB were added had 
oxygen uptake values ranging from 1.8 to 2.0 times the endogenous rates after 210 and 180 minutes, 
respectively (Chambers et al. 1963). In this experiment, the resistance of the nitrobenzenes to 
degradation seemed to decrease as the number of nitro groups on the benzene ring increased 
(Chambers et al. 1963). 
The degradability of 1,3-DNB by microorganisms was studied in environmental samples and in 
laboratory cultures under aerobic conditions (Mitchell and Dennis 1982). After 21 days of incubation 
of 5 µg/mL 1,3-DNB with Tennessee River water samples taken downstream from the Volunteer Army 
Ammunition Plant (a munitions production facility in Chattanooga, Tennessee), the microbially 
mediated disappearance of 1,3-DNB was complete (Mitchell and Dennis 1982). The results showed 
that microorganisms from the Tennessee River could be grown on 1,3-DNB as a sole carbon source 
and could mineralize the compound. The half-life of 1,3-DNB in Tennessee River samples was 
estimated to be one day, assuming a total of one million total microorganisms per mL and a 
temperature of 25 °C. The half-life of 1,3-DNB in enrichment cultures grown on 1,3-DNB was 
9.7 days. The authors concluded that the more rapid rate of 1,3-DNB removal seen during primary 
screening (one day) could result from enhanced biodegradation by microorganisms in a more natural 
state. Results also showed that the enrichment culture was specific for 1,3-DNB. The Tennessee 
River microorganisms grown on 1,3-DNB did not adapt to metabolize 1,3-TNB (MitcheII and Dennis 
1982). 
The transformation of 1,3-DNB was measured in sewage sludge effluent maintained for 28 days under 
aerobic and anaerobic conditions (Hallas and Alexander 1983). Under aerobic conditions, 
approximately 40% was degraded in 28 days, while under anaerobic conditions, approximately 80% 
was degraded in 28 days. Nitroaniline was the product formed from 1,3-DNB degradation under both 
aerobic and anaerobic conditions (Hallas and Alexander 1983). 
5.3.2.3 Sediment and Soil 
1,3-DNB was biodegraded under aerobic conditions to carbon dioxide by a microbial strain, Candida 
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1986). Some biotransformation products detected in the metabolic pathway of biodegradation of 
1,3-DNB included m-nitrophenol, m-aminophenol, resorcinol, fumaric acid, and some volatile fatty 
acids (Dey and Godbole 1986). A pure culture of Rhodococcus sp. isolated from soils contaminated 
with nitroaromatics was capable of using 1,3-DNB as a sole source of nitrogen. This culture 
metabolized 1,3-DNB to nitrite via a 4-nitrocatechol pathway even in the presence of high amounts of 
ammonia (Dickel and Knackmuss 1991). 
Sixteen microorganisms isolated from soil exposed to the waste water effluent from 1,3-DNB 
manufacture had the ability to effectively degrade 1,3-DNB in synthetic media and 1,3-DNB waste 
under aerobic conditions (Dey et al. 1986). The percentage degradation of 1,3-DNB ranged from 32% 
to 87% and from 35% to 92% under stationary and shake culture conditions respectively, in a 
synthetic medium. Streptomyces aminophilus showed maximum degradation both under shake and 
stationary culture conditions, followed by Streptomyces cacaoi, Micromonospora cabali and 
Micrococcus colpogenes. Data on the percentage degradation of 1,3-DNB, based on the percentage 
reduction in chemical oxygen demand (COD) of the 1,3-DNB manufacture waste brought about by 
these organisms, showed that the percentage reduction ranged from 17 to 55% and from 19 to 53% 
under shake and stationary culture conditions, respectively. M. colpogenes gave maximum reduction 
in COD, followed by S. aminophilus, S. cacaoi, and M. cabali. The effects of different environmental 
conditions on 1,3-DNB degradation were also examined (Dey et al. 1986). The isolates were 
inoculated in a synthetic medium and incubated for 7 days under the following conditions: at different 
temperatures-22, 26, 37, and 40 “C; at different pH levels, ranging from 5 to 11; at different 
inoculum densities, from 0.3 to 9 million cells per mL of the medium; and with different periods of 
incubation at room temperature (26 °C) ranging from 3 to 35 days. Under conditions of varying 
temperature, results showed that for all microorganisms there was a rise in percentage degradation with 
a rise in temperature from 22 to 37 °C, followed by a steep fall in percentage degradation with a° 
urther rise in temperature from 37 to 40° C. Data on the percentage degradation under different pH 
levels showed that 13 species belonging to the genera Streptomyces, Micrococcus, Staphylococcus, 
Micromonospora, Candida, Klebsiella, Vibrio, and Aspergillus showed maximum degradation ranging 
from 40 to 87% at pH 9. Only three species belonging to the genera Bacillus showed maximum 
degradation ranging from 38 to 47% at pH 8. Of all the species under study, S. aminophillus gave 
maximum degradation at all pH levels, followed by S. cacaoi and M. colpogenes. Under conditions of 
different inoculum densities, data showed that three million cells per mL of the medium as the 
inoculum density was the optimum for maximum degradation of 1,3-DNB. Under conditions of 
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different incubation periods, data showed that with the longest incubation period (35 days), 100% 
degradation was exhibited by S. aminophilus, S. cacaoi, M. caballi,  M. colpogenes, Micrococcus 
roseus, Micrococcus luteus, Staphylococcus saprophyticus, and Staphylococcus aureus. 
No studies were located regarding the transformation and degradation of 1,3,5-TNB in soil. 
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 
No monitoring studies were located that gave levels of 1,3-DNB or 1,3,5-TNB in air. 
5.4.2 Water 
1,3-DNB and 1,3,5-TNB were detected in effluent (condensate water) from the production and 
purification of trinitrotoluene (TNT) (Spanggord et al. 1982a). 1,3-DNB was detected in 97.5% of the 
54 TNT samples collected over a period of 1 year at concentrations ranging from 0.2 to 8.5 mg/L 
(ppm) (detection limit not reported). 1,3,5-TNB was detected in 3.8% of the 54 TNT samples at 
concentrations ranging from 0.06 to 0.20 mg/L (ppm) (Spanggord et al. 1982a). 
1,3,5-TNB was detected in water from on-site and off-site wells at maximum concentrations of 352 
and 114 ppb, respectively, at the Cornhusker Army Ammunition Plant (CAAP) near Grand Island, 
Nebraska (ATSDR 1989a). CAAP is an NPL site; CAAP is not currently producing or storing 
explosive materials. Present activities at the plant are limited to maintenance operations, leasing of 
property for agriculture and livestock grazing, storage building leasing, and wildlife management 
(ATSDR 1989a). On-site groundwater sampling at the Milan Army Ammunition Plant (MAAP) in 
Tennessee identified 1,3,5-TNB at concentrations ranging from non-detectable to 976 ppb (ATSDR 
1989c). MAAP is an NPL site. From 1942 to 1978, waste water from a munitions demilitarization 
process line was discharged into unlined settling ponds (ATSDR 1989c). The Louisiana Army 
Ammunition Plant (LAAP) is a shell manufacturing and explosives load, assembly, and pack facility 
(Army 1988). From 1951 to 1980, waste waters were trucked to and discharged into a series of 
artificial leaching pits. This resulted in contamination of groundwater, soil, and sediments (Army 
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1.2 to 195 µg/L (ppb) and from 0.8 to 7,720 µg/L (ppb), respectively (Army 1988). 1,3,5-TNB was 
also detected in surface water at LAAP at a concentration of 2 ppm (ATSDR 1989b). 
5.4.3 Sediment and Soil 
1,3,5-TNB has been detected in contaminated soil at the Alabama Army Ammunition Plant in 
Childersburg, Alabama (Army 1981; ATSDR 1987). The contaminants remain from World War II 
production activities. The levels of 1,3,5-TNB detected in soil were 614 ppb (smokeless powder 
manufacturing area), <368-2,540 ppb (magazine area), <368-3,920 ppb and 3,920 ppm (flashing 
ground), and 1,950 ppm (aniline sludge basin) (Army 1981; ATSDR 1987). 1,3,5-TNB was found 
on-site at the Savanna Army Depot (Illinois) in soil samples at a maximum concentration of 2,770 ppb 
(ATSDR 1989d). The Savanna Army Depot is an NPL site. It is an Army munitions plant engaged 
in munitions renovation, loading, demolition, and burning (ATSDR 1989d). 1,3,5-TNB was detected 
in soil samples collected from the Iowa Army Ammunition Plant in 1983 (Army 1985a; Jenkins and 
Grant 1987). Mean levels of 1,3,5-TNB in soil taken from an old ordnance-burning area that had not 
been used since 1981 ranged from 5 1 to 62 µg/g (Army 1985a; Jenkins and Grant 1987). Mean levels 
of 1,3,5-TNB taken from the surface of an old disposal lagoon ranged from 0.27 to 0.45 µg/g (Army 
1985a; Jenkins and Grant 1987). Mean levels of 1,3-DNB detected in field-contaminated soil at an 
Army installation in Tennessee ranged from 0.77 to 1.5 µg/g (Jenkins et al. 1989). 
5.4.4 Other Environmental Media 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
The general population is not likely to be exposed to 1,3-DNB or 1,3,5-TNB. Exposure is expected to 
be limited to populations in areas around Army ammunition plants where 1,3-DNB and 1,3,5-TNB 
have been produced. The most likely route of exposure for populations living in the vicinity of the 
Army ammunition plants is ingestion of contaminated drinking water. Dermal contact with 
contaminated soil is also a possible but unlikely route of exposure. 
Occupational exposure to 1,3-DNB and 1,3,5-TNB can occur when workers handle the compounds in 
explosives plants and other industries, such as dyestuffs, plastics, and rubber, that use these compounds 
during manufacturing processes. The National Occupational Exposure Survey (NOES), conducted by 
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NIOSH from 1981 to 1983, estimated that 2,489 workers were exposed to 1,3-DNB in 41 businesses 
and health services (NOES 1991). The workers included in this survey were chemists (except 
biochemists), geologists, geodesists, clinical laboratory technologists and technicians, and health aides 
(except nursing). 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
Persons living near Army ammunition plants may have a higher risk of exposure to 1,3-DNB and 
1,3,5-TNB resulting from ingestion of contaminated drinking water or contact with contaminated soil. 
5.7 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of 1,3-DNB and 1,3,5-TNB is available. Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 
program of research designed to determine the health effects (and techniques for developing methods 
to determine such health effects) of 1,3-DNB and 1,3,5-TNB. 
The following categories of possible data needs have been identified by a joint team of scientists from 
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met, 
would reduce or eliminate the uncertainties of human health assessment. This definition should not be 
interpreted to mean that all data needs discussed in this section must be filled. In the future, the 
identified data needs will be evaluated and prioritized, and a substance-specific research agenda will be 
proposed. 
5.7.1 Identification of Data Needs 
Physical and Chemical Properties. The physical and chemical properties of 1,3-DNB and
 
1,3,5-TNB are sufficiently characterized to permit estimation of their environmental fate (Army 1987b;
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Production, Import/Export, Use, and Release and Disposal. 1,3-DNB has been produced 
and used commercially in the United States (HSDB 1994). The information that is available on 
production volumes of 1,3-DNB is neither complete not current. DuPont reportedly generates 
70,000-72,000 pounds of 1,3-DNB annually from production of nitro- and dinitro-benzenes (EPA 
1991b). The production volumes of 1,3-DNB by other manufacturers are not known. Data on current 
and past production volumes for 1,3-DNB and 1,3,5-TNB needed for the discussion of production 
trends of these compounds are not available. In 1971, an estimated 10,100 pounds of 1,3-DNB was 
imported into the United States (EPA 1976). No data on either the past or current import/export 
volumes for 1,3,5-TNB were located. Therefore, the history of production and import/export data for 
both 1,3-DNB and 1,3,5-TNB are needed. Both 1,3-DNB and 1,3,5-TNB have been used for their 
explosive properties (HSDB 1994). 1,3-DNB has been suggested as a possible substitute for the 
explosive TNT (HSDB 1994). 1,3,5-TNB has been classified as a high explosive and used in 
explosive compositions (Merck 1989; Sax and Lewis 1987). Commercially, 1,3-DNB has been used in 
organic synthesis and dyes (McFarlane et al. 1987a). 1,3,5-TNB has been used as a vulcanizing agent 
in the processing of natural rubber and as an indicator in acid-base reactions in the pH range of 
12.0-14.0 (HSDB 1994). Exposure to these compounds is limited to areas around Army ammunition 
plants. The most likely route of exposure for populations living near Army ammunition plants is 
ingestion of contaminated drinking water. 
Data on the most commonly used disposal methods are sufficient (EPA 1981; HSDB 1994); however, 
estimates of, amounts disposed of by each method are needed. 1,3-DNB, 1,3,5-TNB, and the wastes 
generated in the manufacture of’ 1,3-DNB and 1,3,5-TNB are classified as EPA hazardous wastes and 
disposal must be carried out according to EPA regulations (HSDB 1994). 
According to the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Section 
11023, industries are required, to submit chemical release and off-site transfer information to the EPA. 
The Toxics Release Inventory (TRI), which contains this information for 1992, became available in 
May of 1994. This database will be updated yearly and should provide a list of industrial production 
facilities and emissions. 
Environmental Fate. Based on its low vapor pressure and low value for Henry’s law constant 
(HSDB 1994), it is unlikely that 1,3,5-TNB will partition to the air from soil or natural bodies of 
water (Lyman et al. 1982). The higher values for vapor pressure and Henry’s law constant (HSDB 
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1994) for 1,3-DNB suggest that it is likely to volatilize from shallow soil or water, but not from deep 
quiescent water or deep soil (Hine and Mookerjee 1975; Lyman et al. 1982). Both compounds are 
mobile in soil and can leach into groundwater. 1,3,5-TNB exhibits a higher mobility than 1,3-DNB 
(Army 1987b; Swann et al. 1983). Neither compound adsorbs to sediments in water to any great 
extent (Swann et al. 1983). Both compounds have the potential to undergo direct photolysis in air 
(EPA 1976; Mill and Mabey 1985); however, no direct atmospheric photolysis studies for either 
compound were located. Therefore, it would be useful to conduct further research to determine the 
effect of photolysis of these compounds in the vapor phase diluted with air. The reaction rate of 
1,3,5-TNB in the presence of photochemically generated hydroxyl radicals is very slow, with an 
atmospheric half-life of 34 years (Atkinson 1985, 1987; HSDB 1994). No studies were located for 
1,3-DNB regarding its reaction with hydroxyl radicals. Hydrolysis is not expected to be an important 
fate process for either compound (Lyman et al. 1982). Both compounds are expected to undergo 
photolysis in water; however, no experimental photolysis data were located for 1,3,5-TNB. 
Experimental data determining the effects of photolysis of 1,3.5-TNB in water would be useful. The 
experimental photolytic half-life of 1,3-DNB in water is 23 days, and the reaction is sensitized by 
humic substances (Simmons and Zepp 1986). 1,3-DNB can undergo biodegradation under aerobic and 
anaerobic conditions in water and soil (Chambers et al. 1963; Mitchell and Dennis 1982). 1,3,5-TNB 
is subject to biodegradation under aerobic conditions in water (Chambers et al. 1963); however, no 
data were located regarding anaerobic biodegradation in water or anaerobic and aerobic biodegradation in 
soil. Further research on the rates of biodegradation of 1,3,5-TNB in water and soil under anaerobic 
conditions, and of biodegradation of 1,3,5-TNB in soil under aerobic conditions would provide valuable 
information. Biodegradation half-life data in water and soil are needed for both compounds. This 
information will be helpful to better identify the most important pathways of human exposure to each 
compound. 
Bioavailability from Environmental Media. Limited data indicate that 1,3-DNB is absorbed in 
humans following inhalation and dermal exposure (Ishihara and Ikeda 1979; Okubo and Shigeta 1982). 
No studies were located regarding absorption of 1,3-DNB following oral exposure. No studies were 
located regarding absorption of 1,3,5-TNB following inhalation, oral, or dermal exposure. More 
information regarding all absorption routes for both compounds, particularly on absorption following 
ingestion of contaminated drinking water and soil or plants grown in contaminated environments, are 
needed to better characterize the bioavailability of 1,3-DNB and 1,3,5-TNB. 
 
95 1,3-DNB AND 1,3,5-TNB 
5. POTENTIAL FOR HUMAN EXPOSURE 
Food Chain Bioaccumulation. Based on low log Kow values, both compounds have a low 
potential for bioaccumulation (Deneer et al. 1987). Based on a low experimental BCF for 1,3-DNB, 
bioaccumulation in aquatic organisms is not an important fate process (Deneer et al. 1987). No BCF 
data were located for 1,3,5-TNB. Data indicate that 1,3-DNB bioaccumulates in plants (McFarlane et 
al. 1987a). No studies were located regarding plant uptake of 1,3,5-TNB. Data are needed regarding 
the bioconcentration and biomagnification potential of both compounds in terrestrial food chains. This 
information would be useful to evaluate the importance of accumulation of these compounds in the 
food chain and on subsequent human exposure to 1,3-DNB and 1,3,5-TNB via the food chain. 
Exposure Levels in Environmental Media. 1,3-DNB and 1,3,5-TNB were detected in 
groundwater and soil at Army ammunition plants (Army 1985a, 1988; ATSDR 1987, 1989a, 1989b, 
1989c; Jenkins and Grant 1987; Jenkins et al. 1989). Data are needed regarding levels of 1,3-DNB 
and 1,3,5-TNB in air. No data were located regarding human intake estimates of 1,3-DNB and 
1,3,5-TNB. This information would be helpful in evaluating human exposure from each medium. 
Reliable monitoring data for these compounds in contaminated media at ammunition plants/waste sites 
are needed so that the information obtained on their levels in the environment, and the resulting body 
burden caused, can be used to assess the potential risk of adverse health effects in populations living 
near ammunition plants/waste sites. 
Exposure Levels in Humans. 1,3-DNB and 1,3,5-TNB have not been detected in human blood, 
urine, fat, or breast milk; however, 1,3-DNB has been detected in the urine and blood of rodents fed 
the compound (Bailey et al. 1988; McEuen and Miller 1991; Nystrom and Rickert 1987). Biological 
monitoring data for both 1,3-DNB and 1,3,5-TNB are needed for populations living near Army 
ammunition plants and for occupationally exposed populations. This information is necessary for 
assessing the need to conduct, studies on these populatrons. 
Exposure Registries. No exposure registries were located for 1,3-DNB and 1,3,5-TNB. This 
compound is not currently one of the compounds for which a subregistry has been established in the 
National Exposure Registry. The compound will be considered in the future when chemical selection 
is made for subregistries to be established. The information that is amassed in the National Exposure 
Registry facilitates the epidemiological research needed to assess adverse health outcomes that may be 
related to the exposure to this compound. 
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5.7.2 Ongoing Studies 
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The purpose of this chapter is to describe the analytical methods that are available for detecting and/or 
measuring and monitoring 1,3-DNB and 1,3,5-TNB in environmental media and in biological samples. 
The intent is not to provide an exhaustive list of analytical methods that could be used to detect and 
quantify 1,3-DNB and 1,3,5-TNB. Rather, the intention is to identify well-established methods that 
are used as the standard methods of analysis. Many of the analytical methods used to detect I,3-DNB 
and 1,3,5-TNB in environmental samples are the methods approved by federal organizations such as 
EPA and the National Institute for Occupational Safety and Health (NIOSH). Other methods 
presented in this chapter may be those that are approved by groups such as the Association of Official 
Analytical Chemists (AOAC) and the American Public Health Association (APHA). Additionally, 
analytical methods may be included that refine previously. used methods to obtain lower detection 
limits, and/or to improve accuracy and precision. 
6.1   BIOLOGICAL SAMPLES 
The data on analytical methods for detecting 1,3-DNB and 1,3,5-TNB and their metabolites in 
biological media are very limited. The few methods that have been used are discussed in the 
following section and summarized in Table 6-l. 
1,3-DNB and its metabolites have been determined in the blood and urine of rodents fed the 
compound (Bailey et al. 1988; McEuen and Miller 1991; Nystrom and Rickert 1987). The methods to 
detect 1,3-DNB include high-resolution gas chromatography (HRGC) with electron capture detection 
(ECD), high-performance liquid chromatography (HPLC) with radioactivity detection (RAD) (for 
radiolabeled compounds) or ultraviolet (UV) detection or liquid scintillation counting (LSC) (for 
radiolabeled compounds), gas chromatography (GC) with mass spectrometry (MS), and 
spectrophotometry. It should be noted that the HPLC/RAD method is not suitable for the 
determination of 1,3-DNB and its metabolites in humans since it requires exposure to radiolabeled 
compounds. A reported method for quantitating 1,3-DNB and its metabolites in blood and urine by 
HRGC/ECD has a limit of detection in the low ppb range, and both recovery (≈110%) and precision 
(±3% coefficient of variation [CV]) of the method were excellent (Bailey et al. 1988). The reported 
methods based on HPLC separation and detection/quantification of radioactivity (McEuen and Miller 
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or tested. Table 6-2 contains a summary of several representative methods for determining 1,3-DNB 
and 1,3,5-TNB in various environmental media. Methods in which nitrobenzene was the analyte have 
been included when the methods apply to 1,3-DNB and 1,3,5-TNB as well. For several of the 
methods included in Table 6-2, nitrobenzene is the analyte being investigated, although the method 
should also be useful for analysis of 1,3-DNB and/or 1,3,5-TNB (when nitrobenzene data were used, 
this is indicated in the Sample column). 
The few methods located for analysis of nitro compounds in air have not been well characterized for 
1,3-DNB or 1,3,5-TNB. Only one method considered the analysis of 1,3-DNB specifically. The 
remainder were for analysis of nitrobenzene but could also be applied to the analysis of 1,3-DNB or 
1,3,5-TNB. Most air samples are preconcentrated by collection on a solid sorbent prior to 
measurement; however, grab samples or liquid impingers have been used in some methods for the 
collection of 1,3-DNB. HRGC and GC with FID have been used to measure 1,3-DNB and 
nitrobenzene in air samples (Andersson et al. 1983; Cooper et al. 1986; Kebbekus and Bozzelli 1982). 
Under the experimental conditions used, reliability was adequate, with accuracy ranging from 52 to 
84% and precisions ranging from 6 to 30% CV (Andersson et al. 1983; Kebbekus and Bozzelli 1982). 
The lower recoveries and precisions were obtained with nitrobenzene (Kebbekus and Bozzelli 1982) 
and could be substantially different for 1,3-DNB and 1,3,5-TNB. However, tests with 1,3-DNB and 
1,3,5-TNB would have to be conducted to determine reliability parameters for these compounds. 
Sensitivity for HRGC/FID using nitrobenzene as the analyte was in the low ppt (Kebbekus and 
Bozzelli 1982). A comparison of HRGC with either NPD or FID showed that NPD was far more 
selective for nitro compounds than FID (Cooper et al. 1986). The detection limit for HRGC/NPD 
under the conditions used was in the. low ppb, and the authors could not quantify nitrobenzene using 
HRGCYFID. A spectrophotometric method has been developed for detection of nitro and amino 
benzene-based compounds in air (Dangwal 1981). Since the method cannot differentiate between the 
various nitro- and amino-benzene compounds, it is substantially less selective than other available 
methods. The sample preparation is more complex than with other tested methods and involves 
extraction with carbon tetrachloride, a potentially hazardous chemical. In addition, the sensitivity is 
several orders of magnitude less (ppm) than the’sensitivity of the HRGC and GC methods. 
Both GC (high and low resolution) and HPLC may be used to separate nitrobenzene compounds in 
water. The most common detector for HPLC analysis is UV. For the GC methods, several detectors 
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sub to a mid-ppb range depending on the method, contamination level of the sample, efficiency of the 
extraction procedure, selectivity of the method, specific analyte (nitrobenzene, 1,3-DNB, or 
1,3,5-TNB), and other method variables. The sensitivity of the GC-based methods is in the low-ppb 
range, with the limited data suggesting that ECD and FID may be slightly more sensitive than the 
other tested detectors (Austem et al. 1975; Richard and Junk 1986). However, TEA (Feltes et al. 
1990), nitrogen-phosphorus (Army 1986), and MS (EPA 1986a; Feltes et al. 1990; Stemmler and Hites 
1987) detectors are considered much more selective. GC/MS using a low-resolution instrument in 
electron ionization mode is the method recommended by EPA (EPA 1986a) because of its selectivity and 
sensitivity. However, other studies have shown that negative chemical ionization (NCI) and electron 
capture NCI are more sensitive and reliable than the EPA method (Feltes et al. 1990; 
Stemmler and Hites 1987). HPLC provides an alternative to GC-based methods (Army 1983, 1989; 
Feltes and Levsen 1989). The HPLC methods available are sensitive (detection limits ranging from 
low ppt to low ppb), relatively selective, reproducible, and reliable, in that they maintain the integrity 
of samples (sample decomposition may occur in heated zones of GC injectors). HPLC is also simple 
and rapid, requiring little sample preparation. A modification of the HPLC/UV method couples two 
UV detectors and a PC detector (Army 1989). This arrangement of detectors can improve the 
selectivity of HPLC substantially. An MS technique that allows direct injection of a water sample has 
also been tested (Yinon and Laschever 1982). The detection limit was only in the low-ppm range, but 
its selectivity makes it a good method for screening samples for further analysis. Assays based on 
COD and TOC (Roth and Murphy 1978) are well-established standard methods for determining 
organic pollution in water, but they are not selective for nitrobenzene compounds. 
HPLC/UV was the only method located for measuring nitrobenzene, 1,3-DNB, and 1,3,5-TNB in soil 
(Army 1985a; Bauer et al. 1990; Jenkins and Grant 1987; Jenkins et al. 1989). This method, 
developed by the Army, has been extensively tested and has been proven to be selective and reliable, 
giving high recoveries and good precision for complex samples. Sensitivity in the low-ppm range has 
been reported. A similar method, with less rigid sample clean-up, had recoveries for nitrobenzene that 
varied widely (Grob and Cao 1990). This shows the importance of sample extraction and clean-up 
with regard to results when the matrix is complex. 
Cyclic voltammetry and differential pulse voltammetry have been used to analyze wine, beer, and cider 
for nitrobenzene (Lorenzo et al. 1988). While no detection limits were reported, amounts as low as 0.5 
mg/L were easily detected and precision was excellent (±5% CV). An advantage of this method is 
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that the analyte can be measured by direct insertion of the electrode in the solution. The method 
should also apply to the detection of 1,3-DNB and 1,3,5-TNB in solutions because it is based on 
polarographic determination of the nitro group. However, it is not as selective as HPLC- and 
GC-based methods. MS/MS has been investigated as a screening method for explosives (McLuckey et 
al. 1985), but no data on the sensitivity and reliability of this method were available. A supercritical 
fluid capillary chromatographic method with FID detection has been proposed for the determination of 
a broad range of compounds (including nitroaromatics) in solid wastes (Pospisil et al. 1991). The 
method was used to chromatograph over 270 compounds on a single column within 1 hour. 
6.3 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of 1,3-DNB and 1,3,5-TNB is available. Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 
program of research designed to determine the health effects (and techniques for developing methods 
to determine such health effects) of 1,3-DNB and 1,3,5-TNB. 
The following categories of possible data needs have been identified by a joint team of scientists from 
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met, 
would reduce or eliminate the uncertainties of human health assessment. This definition should not be 
interpreted to mean that all data needs discussed in this section must be filled. In the future, the 
identified data needs will be evaluated and prioritized, and a substance-specific research agenda will be 
proposed. 
6.3.1 dentification of Data Needs 
Methods for Determining Biomarkers of Exposure and Effect. Very few methods were 
located that could be used to determine exposure to 1,3-DNB or 1,3,5-TNB in humans. A 
spectrophotometric method exists (Dangwal and Jethani 1980) but is selective for nitro and amino 
benzene-based compounds, not for 1,3-DNB and 1,3,5-TNB specifically. The best methods for 
determination of exposure to 1,3-DNB and 1,3,5-TNB are HRGUECD (Bailey et al. 1988) and 
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for detection of 1,3-DNB and metabolites in blood and urine. The method has a detection limit of 
10 ppb, a recovery of 110% and a coefficient of variation of 23% (Bailey et al. 1988). Since there is 
no database for the levels of 1,3-DNB and 1,3,5-TNB in human biological tissues or body fluids (other 
than in cases of accidental exposure), it is not possible to determine whether the existing analytical 
methods are sensitive enough to measure the background levels of the parent compound or metabolites 
in the general population or to measure the concentration levels at which biological effects occur in 
humans. Further testing and improvement of existing methods and development of new methods are 
needed for monitoring populations with potential for exposure to 1,3-DNB or 1,3,5-TNB. 
Methemoglobinemia is a primary biomarker of effect for 1,3-DNB and 1,3,5-TNB. Well-established 
and reliable methods exist for monitoring methemoglobin formation using a complete blood count 
(Ishihara et a1.1976). However, methemoglobinemia is not a specific effect of 1,3-DNB and 
1,3,5-TNB; other chemicals also cause methemoglobin formation. Other effects of exposure to 
1,3-DNB and 1,3,5-TNB (cyanosis, headache, nausea, dizziness) are very general and cannot be 
quantified. Therefore, it would be useful to conduct further research to develop biomarkers of effect 
of exposure to 1,3-DNB and 1,3,5-TNB. 
Methods for Determining Parent Compounds and Degradation Products in 
Environmental Media. Several methods for determining 1,3-DNB and 1,3,5-TNB in 
environmental media have been developed and tested. In addition, some methods that have been 
developed for detection of nitrobenzene can also be used for detection of 1,3-DNB and 1,3,5-TNB 
(Cooper et al. 1986; Dangwal 1981; Kebbekus and Bozzelli 1982; Lorenzo et al. 1988). The methods 
expected to be most sensitive and selective for detecting the analytes in air are GC-based with 
detection by FID or NPD (Andersson et al. 1983; Cooper et al. 1986; Kebbekus and Bozzelli 1982). 
More data on these methods when used specifically to test for 1,3-DNB and 1,3,5-TNB are needed, 
because Andersson et al. (1983) provided no information regarding the detection limit of the GUFID 
method used for the determination of 1,3-DNB in air, and very few published methods are available 
that give that information. Both HPLC/UV and GC (high-resolution or low-resolution), combined with 
one of several detectors (NPD, ECD, FID, TEA, and MS), yield good results when water is analyzed for 
nitrobenzene compounds (Army 1983, 1986, 1989; Austem et al. 1975; EPA 1986a; Feltes and Levsen 
1989; Feltes et al. 1990; Richard and Junk 1986; Stemmler and Hites 1987). Some of these methods have 
not been fully developed for analysis of 1,3-DNB and 1,3,5-TNB (Army 1983, 1989; Austem et al. 1975; 
EPA 1986a; Stemmler and Hites 1987). A detection limit of <0.1 µg/L and a 
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recovery of 74-89s has been reported for 1,3-DNB and 1,3,5-TNB in tap water by HRGC/ECD 
methodology (Richard and Junk 1986). Further testing of these methods specifically designed to 
determine their usefulness for measuring 1,3-DNB and 1,3,5-TNB in water would be helpful because 
no detection limit has been reported for the determination of these compounds in water by other 
promising methods, such as HPLC/UV/UV/PC (Army 1989) and GC/NPD following sample 
concentration by a suitable solid adsorbent during collection. The method currently used for detection 
of 1,3-DNB and 1,3,5-TNB in soil is reliable (Army 1985a; Jenkins et al. 1989), but increased 
sensitivity would allow better detection of trace levels in potentially contaminated soils. Since the 
background levels of 1,3-DNB and 1,3,5-TNB in ambient air, water and soil have not been established, it 
is not possible to determine whether the existing methods would be sensitive enough to measure 1,3-DNB 
and 1,3,5-TNB concentrations in background samples. Very little data were located on methods of 
analyzing for 1,3-DNB and 1,3,5-TNB in other media. The methods located for detection of the analytes 
in both beverages (Lorenzo et al. 1988) and explosives (McLuckey et al. 1985) were still in the 
developmental stages. Methods for analyzing these compounds in other media, especially in foods, plants, 
and aquatic and terrestrial organisms, are needed. 
Some of the aerobic and anaerobic biodegradation products of 1,3-DNB in the environment are 
1,3-nitroaniline, 1,3-phenylenediamine, 1,3-nitrophenol, 1,3-aminophenol and resorcinol 
(1,3-dihydroxyphenol) (Dey and Godbole 1986; Hallas and Alexander 1983; Reddy et al. 1993). A 
reversed-phase HPLWUV method is available for the determination of reduction products of 
1,3-dinitrobenzene in the presence of 1,3-DNB and 1,3,5-TNB (Reddy et al. 1993). The derivatization 
of the amino-group with trifluoroacetic anhydride may increase the sensitivity of 1,3-nitroaniline and 
1,3-phenylenediamine determination by the HPLCXJV method (Preslan et al. 1993). However, this 
method has not been standardized for the determination of reduction products of 1,3-DNB and 
1,3,5-TNB. 
6.3.2 Ongoing Studies 
No ongoing studies regarding analytical methods were’ located for either 1,3-DNB or 1,3,5-TNB. 
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The international, national, and state regulations and guidelines regarding 1,3-DNB and 1,3,5-TNB in 
air, water, and other media are summarized in Table 7-l. 
ATSDR has derived two MRL values for 1,3-DNB. An acute-duration oral MRL of 0.08 mg/kg/day 
was derived for 1,3-DNB based on a NOAEL for testicular damage in male rats administered a single 
dose of 1,3-DNB by gavage (Linder et al. 1990). 
An intermediate-duration oral MRL of 0.0005 mg/kg/day was derived for 1,3-DNB based on a 
LOAEL for hematological effects in male rats administered 1,3-DNB by gavage intermittently for 12 
weeks (Linder et al. 1986). 
The EPA reference dose (RfD) is 1x10-4 mg/kg/day for 1,3-DNB and is based on spleen enlargement 
in rats (IRIS 1994). The EPA RfD for 1,3,5-TNB is 5x10-5 mg/kg/day and is extrapolated from the 
RfD for 1,3-DNB based on the structural similarity. 
EPA has assigned 1,3-DNB a weight-of-evidence carcinogenic classification of D, which indicates that 
1,3-DNB is not classifiable as to human carcinogenicity (IRIS 1994). EPA has not assigned a weightof-
evidence carcinogenic classification for 1,3,5-TNB. 
1,3-DNB and 1,3,5-TNB are designated as hazardous substances (EPA 1978, 1987b) and are subject to 
groundwater monitoring requirements (EPA 1987a, 1988b). 
The transportation.of explosives, including 1,3-DNB and 1,3,5-TNB, must be in accordance with the 
Department of Transportation hazardous material regulations (49 CFR 171-190) and the motor carrier 
safety regulations (49 CFR 390-398). Numerous states have established regulations on explosives for 
air quality control, solid waste disposal, storage, manufacture, and use. 
OSHA requires employers of workers who are occupationally exposed to 1,3-DNB to institute 
engineering controls and work practices to reduce and maintain employee exposure at or below 
permissible exposure limits (PEL). The employer must use engineering and work practice controls, if 
feasible, to reduce exposure to or below an 8-hour time-weighted average (TWA) of 1.0 mg/m3 (skin 
110 1,3-DNB AND 1,3,5-TNB 
7. REGULATIONS AND ADVISORIES 
designation) for 1,3-DNB. No value has been designated for 1,3,5-TNB. Respirators must be 
provided and used during the time period necessary to install or implement feasible engineering and 
work practice controls. Also, special protective measures should be taken to significantly reduce or 
preclude skin contact. 
1,3-DNB is regulated as a toxic chemical under the Emergency Planning and Community Right-tol$ 
now Act (EPCRA) (EPA 1986c) and the Toxic Substances Control Act (TSCA) for preliminary 
assessment of new products (EPA 1982a) and health and safety data reporting (EPA 1982b). 
The Resource Conservation and Recovery Act (RCRA) identifies both compounds for groundwater 
monitoring at hazardous waste management facilities (EPA 1987a). RCRA also designates 1,3,5-TNB 
as a hazardous waste when it occurs as a discarded commercial product, off-spec species, container -
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified in the 
Toxicological Profiles. 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical adsorbed per unit weight of 
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium. 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e., the solid 
phase) divided by the amount of chemical in the solution phase, which is in equilibrium with the solid 
phase, at a fixed solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per 
gram of soil or sediment. 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in aquatic 
organisms at a specific time or during a discrete time period of exposure divided by the concentration 
in the surrounding water at the same time or during the same period. 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies, that 
produces significant increases in the incidence of cancer (or tumors) between the exposed population 
and its appropriate control. 
Carcinogen -- A chemical capable of inducing cancer. 
Ceiling Value -- A concentration of a substance that should not be exceeded, even instantaneously. 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the Toxicological 
Profiles. 
Developmental Toxicity -- The occurrence of adverse effects on the developing organism that may 
result from exposure to a chemical prior to conception (either parent), during prenatal development, or 
postnatally to the time of sexual maturation. Adverse developmental effects may be detected at any 
point in the life span of the organism. 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of prenatal exposure 
to a chemical; the distinguishing feature between the two terms is the stage of development during 
which the insult occurred. The terms, as used here, include malformations and variations, altered 
growth, and in utero death. 
EPA Health Advisory -- An estimate of acceptable drinking water levels for a chemical substance 
based on health effects information. A health advisory is not a legally enforceable federal standard, 
but serves as technical guidance to assist federal, state, and local officials. 
Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration of 
a contaminant from which one could escape within 30 min without any escape-impairing symptoms or 
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Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as specified in the 
Toxicological Profiles. 
Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may result 
from exposure to environmental agents such as chemicals. 
In vitro -- Isolated from the living organism and artificially maintained, as in a test tube. 
In vivo -- Occurring within the living organism. 
Lethal Concentration(LO) (LCLO) -- The lowest concentration of a chemical in air which has been 
reported to have caused death in humans or animals. 
Lethal Concentratiox(50) (LC50) -- A calculated concentration of a chemical in air to which exposure 
for a specific length of time is expected to cause death in 50% of a defined experimental animal 
population. 
Lethal DosecLO) (LO) -- The lowest dose of a chemical introduced by a route other than inhalation 
that is expected to have caused death in humans or animals. 
Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to cause death in 50% of 
a defined experimental animal population. 
Lethal Time(50) (LT50) -- A calculated period of time within which a specific concentration of a 
chemical is expected to cause death in 50% of a defined experimental animal population. 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study, or 
group of studies, that produces statistically or biologically significant increases in frequency or severity 
of adverse effects between the exposed population and its appropriate control. 
Malformations -- Permanent structural changes that may adversely affect survival, development, or 
function. 
Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is likely to 
be without an appreciable risk of adverse noncancerous effects over a specified duration of exposure. 
Mutagen -- A substance that causes mutations. A mutation is a change in the genetic material in a 
body cell. Mutations can lead to birth defects, miscarriages, or cancer. 
Neurotoxicity -- The occurrence of adverse effects on the nervous system following exposure to 
chemical. 
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no 
statistically or biologically significant increases in frequency or severity of adverse effects seen 
between the exposed population and its appropriate control. Effects may be produced at this dose, but 
they are not considered to be adverse. 
Octanol-Water Partition Coeficient (KOW) -- The equilibrium ratio of the concentrations of a 
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Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace air averaged over an 
8-hour shift. 
q1* -- The upper-bound estimate of the low-dose slope of the dose-response curve as determined by 
the multistage procedure. The q1* can be used to calculate an estimate of carcinogenic potency, the 
incremental excess cancer risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and 
µg/m3 for air). 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of magnitude) of 
the daily exposure of the human population to a potential hazard that is likely to be without risk of 
deleterious effects during a lifetime. The RfD is operationally derived from the NOAEL (from animal 
and human studies) by a consistent application of uncertainty factors that reflect various types of data 
used to estimate RfDs and an additional. modifying factor, which is based on a professional judgment 
of the entire database on the chemical. The RfDs are not applicable to nonthreshold effects such as 
cancer. 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is considered reportable 
under CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances, an 
amount established by regulation either under CERCLA or under Sect. 311 of the Clean Water Act. 
Quantities are measured over a 24-hour period. 
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system that may 
result from exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the 
related endocrine system. The manifestation of such toxicity may be noted as alterations in sexual 
behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the 
integrity of this system. 
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be 
exposed for up to 15 min continually. No more than four excursions are allowed per day, and there 
must be at least 60 min between exposure periods. The daily TLV-TWA may not be exceeded. 
Target Organ Toxicity -- This term covers a broad range of adverse effects on target organs or 
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited 
exposure to those assumed over a lifetime of exposure to a chemical. 
Teratogen -- A chemical that causes structural defects that affect the development of an organism. 
Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can be 
exposed without adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL. 
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal 8-
hour workday or 40-hour workweek. 
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than inhalation, 
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population. 
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Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from experimental data. 
Ufs are intended to account for (1) the variation in sensitivity among the members of the human 
population, (2) the uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in 
extrapolating from data obtained in a study that is of less than lifetime exposure, and (4) the 
uncertainty in using LOAEL data rather than NOAEL data. Usually each of these factors is set equal 
to 10. 





Public Health Statement 
This chapter of the profile is a health effects summary written in non-technical language. Its intended 
audience is the general public especially people living in the vicinity of a hazardous waste site or 
chemical release. If the Public Health Statement were removed from the rest of the document, it 
would still communicate to the lay public essential information about the chemical. 
The major headings in the Public Health Statement are useful to find specific topics of concern. The 
topics are written in a question and answer format. The answer to each question includes a sentence 
that will direct the reader to chapters in the profile that will provide more information on the given 
topic. 
Chapter 2 
Tables and Figures for Levels of Significant Exposure (LSE) 
Tables (2-1, 2-2, and 2-3) and figures (2-1 and 2-2) are used to summarize health effects and illustrate 
graphically levels of exposure associated with those effects. These levels cover health effects observed 
at increasing dose concentrations and durations, differences in response by species, minimal risk levels 
(MRLS) to humans for noncancer endpoints, and EPA’s estimated range associated with an 
upper-bound individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. Use the LSE tables and 
figures for a quick review of the health effects and to locate data for a specific exposure scenario. The 
LSE tables and figures should always be used in conjunction with the text. All entries in these tables 
and figures represent studies that provide reliable, quantitative estimates of No-Observed-Adverse-
Effect Levels (NOAELs), Lowest-Observed-Adverse-Effect Levels (LOAELs), or Cancer Effect Levels 
(CELs). 
The legends presented below demonstrate the application of these tables and figures. Representative 
examples of LSE Table 2-1 and Figure 2-1 are shown. The numbers in the left column of the legends 
correspond to the numbers in the example table and figure. 
LEGEND 
See: LSE Table 2-1 
(1) Route of Exposure One of the first considerations when reviewing the toxicity of a substance
     using these tables and figures should be the relevant and appropriate route of exposure. When
     sufficient data exists, three LSE tables and two LSE figures are presented in the document. The
     three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, and
    dermal (LSE Table 2-1, 2-2, and 2-3, respectively). LSE figures are limited to the inhalation

    (LSE Figure 2-l) and oral (LSE Figure 2-2) routes. Not all substances will have data on each
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(2) Exposure Period Three exposure periods - acute (less than 15 days), intermediate (15-364 days),
     and chronic (365 days or more) are presented within each relevant route of exposure. In this
     example, an inhalation study of intermediate exposure duration is reported. For quick reference
     to health effects occurring from a known length of exposure, locate the applicable exposure
     period within the LSE table and figure. 
(3) Health Effect The major categories of health effects included in LSE tables and figures are
     death, systemic, immunological, neurological, developmental, reproductive, and cancer.
     NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.
     Systemic effects are further defined in the “System” column of the LSE table (see key number
 18). 
(4) Key to Figure Each key number in the LSE table links study information to one or more data
     points using the same key number in the corresponding LSE figure. In this example, the study
     represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL
    (also see the 2 “18r” data points in Figure 2-l). 
(5) Species The test species, whether animal or human, are identified in this column, Section 2.4,
     “Relevance to Public Health,” covers the relevance of animal data to human toxicity and Section
     2.3, “Toxicokinetics,” contains any available information on comparative toxicokinetics.
     Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent
    human doses to derive an MRL. 
(6) Exposure Frequency/Duration The duration of the study and the weekly and daily exposure
      regimen are provided in this column. This permits comparison of NOAELs and LOAELs from
     different studies. In this case (key number 18), rats were exposed to toxaphene via inhalation for
     6 hours per day, 5 days per week, for 3 weeks. For a more complete review of the dosing
     regimen refer to the appropriate sections of the text or the original reference paper, i.e., Nitschke
 et al. 1981. 
(7) System This column further defines the systemic effects. These systems include: respiratory,
      cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dernWocu1a.r.
     “Other” refers to any systemic effect (e.g., a decrease in body weight) not covered in these

      systems. In the example of key number 18, 1 systemic effect (respiratory) was investigated.
 
(8) NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at which
      no harmful effects were seen in the organ system studied. Key number 18 reports a NOAEL of
      3 ppm for the respiratory system which was used to derive an intermediate exposure, inhalation
      MRL of 0.005 ppm (see footnote “b”). 
(9) LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest dose used in the
      study that caused a harmful health effect. LOAELs have been classified into “Less Serious” and
      “Serious” effects. These distinctions help readers identify the levels of exposure at which
      adverse health effects first appear and the gradation of effects with increasing dose. A brief
      description of the specific endpoint used to quantify the adverse effect accompanies the LOAEL.
      The respiratory effect reported in key number 18 (hyperplasia) is a Less serious LOAEL of 10
      ppm. MRLs are not derived from Serious LOAELs. 
(10) Reference The complete reference citation is given in chapter 8 of the profile. 
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(11) CEL A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of
       carcinogenesis in experimental or epidemiologic studies. CELs are always considered serious
       effects. The LSE tables and figures do not contain NOAELs for cancer, but the text may report 
doses not causing measurable cancer increases. 
(12) Footnotes Explanations of abbreviations or reference notes for data in the LSE tables are found
       In the footnotes. Footnote “b” indicates the NOAEL of 3 ppm in key number 18 was used to 
derive an MRL of 0.005 ppm. 
LEGEND 
See Figure 2-1 
LSE figures graphically illustrate the data presented in the corresponding LSE tables. Figures help the 
reader quickly compare health effects according to exposure concentrations for particular exposure 
periods. 
(13) Exposure Period The same exposure periods appear as in the LSE table. In this example, health
       effects observed within the intermediate and chronic exposure periods are illustrated. 
(14) Health Effect These are the categories of health effects for which reliable quantitative data
        exists. The same health effects appear in the LSE table. 
(15) Levels of Exposure concentrations or doses for each health effect in the LSE tables are 
graphically displayed in the LSE figures. Exposure concentration or dose is measured on the log
       scale “y” axis. Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in
       mg/kg/day . 
(16) NOAEL In this example, 18r NOAEL is the critical endpoint for which an intermediate
       inhalation exposure MRL is based. As you can see from the LSE figure key, the open-circle
       symbol indicates to a NOAEL for the test species-rat. The key number 18 corresponds to the
       entry in the LSE table. The dashed descending arrow indicates the extrapolation from the
       exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005 ppm (see footnote “b”
       in the LSE table). 
(17) CEL. Key number 38r is 1 of 3 studies for which Cancer Effect Levels were derived. The 
diamond symbol refers to a Cancer Effect Level for the test species-mouse. The number 38
       corresponds to the entry in the LSE table. 
(18) Estimated Upper-Bound Human Cancer Risk Levels This is the range associated with the 
upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. These risk levels are 
derived from the EPA’s Human Health Assessment Group’s upper-bound estimates of the slope 
of the cancer dose response curve at low dose levels (qi*). 
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Chapter 2 (Section 2.4) 
Relevance to Public Health 
The Relevance to Public Health section provides a health effects summary based on evaluations of 
existing toxicologic, epidemiologic, and toxicokinetic information. This summary is designed to 
present interpretive, weight-of-evidence discussions for human health endpoints by addressing the 
following questions. 
What effects are known to occur in humans? 
2 . What effects observed in animals are likely to be of concern to humans? 
3 . What exposure conditions are likely to be of concern to humans, especially around hazardous
 waste sites? 
The section covers endpoints in the same order they appear within the Discussion of Health Effects by 
Route of Exposure section, by route (inhalation, oral, dermal) and within route by effect. Human data 
are presented first, then animal data. Both are organized by duration (acute, intermediate, chronic). In 
vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also 
considered in this section. If data are located in the scientific literature, a table of genotoxicity 
information is included. 
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using 
existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does not currently assess cancer 
potency or perform cancer risk assessments. Minimal risk levels (MRLs) for noncancer endpoints (if 
derived) and the endpoints from which they were derived are indicated and discussed. 
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to 
public health are identified in the Data Needs section. 
Interpretation of Minimal Risk Levels 
Where sufficient toxicologic information is available, we have derived minimal risk levels (MRLs) for 
inhalation and oral routes of entry at each duration of exposure (acute, intermediate, and chronic). 
These MRLs are not meant to support regulatory action; but to acquaint health professionals with 
exposure levels at which adverse health effects are not expected to occur in humans. They should 
help physicians and public health officials determine the safety of a community living near a chemical 
emission, given the concentration of a contaminant in air or the estimated daily dose in water. MRLs 
are based largely on toxicological studies in animals and on reports of human occupational exposure. 
MRL users should be familiar with the toxicologic information on which the number is based, 
Chapter 2.4, “Relevance to Public Health,” contains basic information known about the substance. 
Other sections such as 2.6, “Interactions with Other Substances,” and 2.7, “Populations that are 
Unusually Susceptible” provide important supplemental information. 
MRL users should also understand the MRL derivation methodology. MRLs are derived using a 
modified version of the risk assessment methodology the Environmental Protection Agency (EPA) 
provides (Barnes and Dourson 1988) to determine reference doses for lifetime exposure (RIDS). 
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To derive an MRL, ATSDR generally selects the most sensitive endpoint which, in its best judgement, 
represents the most sensitive human health effect for a given exposure route and duration. ATSDR 
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is 
available for all potential systemic, neurological, and developmental effects. If this information and 
reliable quantitative data on the chosen endpoint are available, ATSDR derives an MRL using the 
most sensitive species (when information from multiple species is available) with the highest NOAEL 
that does not exceed any adverse effect levels. When a NOAEL is not available, a 
lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty 
factor (UF) of 10 must be employed. Additional uncertainty factors of 10 must be used both for 
human variability to protect sensitive subpopulations (people who are most susceptible to the health 
effects caused by the substance) and for interspecies variability (extrapolation from animals to 
humans). In deriving an MRL, these individual uncertainty factors are multiplied together. The 
product is then divided into the inhalation concentration or oral dosage selected from the study. 
Uncertainty factors used in developing a substance-specific MRL are provided in the footnotes of the 
LSE Tables. 







